This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Demyelinating diseases of the central nervous system
G6_DEMYEL
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersNone 0 out of 7 registries used, show all original rules. |
0 |
4. Check minimum number of eventsNone |
0 |
5. Include endpoints |
3650 |
6. Filter based on genotype QC (FinnGen only) |
3650 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 2
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Demyelinating diseases of the central nervous system
based on the number of shared cases.
Similar with more cases:
- Autoimmune diseases
- Used for control exclusion in common control thyroid runs
- Neurological diseases
- Neurological diseases, wide definition
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No data for upset plot.
No data for upset table.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 3650 | 2678 | 972 |
| Unadjusted period prevalence (%) | 0.78 | 0.91 | 0.43 |
| Median age at first event (years) | 38.19 | 36.94 | 41.64 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 3291
- Matched controls
- 32908
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
L03AB08
ATC
interferon beta-1b; parenteral
+∞
323.0
382
*
TAB00
NOMESCO Finland
Lumbar puncture
22.9
323.0
1052
660
303
Kela drug reimbursment
Dimethyl fumarate, interferon beta, glatiramer acetate and teriflunomid (Multiple sclerosis)
+∞
323.0
1579
*
353
Kela drug reimbursment
Cladribine and fingolimod
+∞
323.0
386
*
157
Kela drug reimbursment
Dimethyl fumarate, glatiramer acetate, interferon beta and teriflunomid (Multiple sclerosis)
+∞
323.0
1503
*
N04BB01
ATC
amantadine; oral
57.3
323.0
518
107
L04AA27
ATC
fingolimod; oral
+∞
323.0
321
*
109
Kela drug reimbursment
Multiple sclerosis
+∞
323.0
1876
*
L04AX07
ATC
dimethyl fumarate; oral
+∞
323.0
510
*
G35
ICD-10 Finland
Multiple sclerosis
15871.4
323.0
2679
6
L04AA31
ATC
teriflunomide; oral
+∞
323.0
408
*
L03AX13
ATC
glatiramer acetate; parenteral
+∞
323.0
672
*
164
Kela drug reimbursment
Fingolimod
+∞
323.0
438
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
20.3
323.0
1443
1218
H46
ICD-10 Finland
Optic neuritis
178.2
323.0
735
53
G37.9
ICD-10 Finland
Demyelinating disease of central nervous system, unspecified
14605.3
323.0
1027
*
N07XX09
ATC
[U] dimethyl fumarate; oral
+∞
323.0
333
*
N86
ICPC
Multiple sclerosis
2009.4
323.0
764
5
L03AB07
ATC
interferon beta-1a; parenteral
+∞
323.0
867
*
M03BX01
ATC
baclofen; systemic
29.2
318.3
438
172
G36.9
ICD-10 Finland
Acute disseminated demyelination, unspecified
+∞
249.2
236
*
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
31.2
245.9
332
118
XA800
NOMESCO Finland
Neuropsychological investigation
10.6
222.2
455
489
2AB04
NOMESCO Finland
NA
173.2
216.8
226
14
R20.2
ICD-10 Finland
Paraesthesia of skin
6.3
215.4
633
1196
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
15.2
213.9
367
269
3400A
ICD-9 Finland
Multiple sclerosis[SCLEROSIS MULTIPLEX (DISSEMINATA)]
+∞
210.7
200
*
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
5.7
197.1
626
1293
XKD06
NOMESCO Finland
Physiologic investigation of micturition
13.8
193.4
346
278
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
5.4
191.6
639
1395
F02.89*G35
ICD-10 Finland
Dementia in multiple sclerosis
+∞
191.5
182
*
XCK00
NOMESCO Finland
Perimetry
6.9
172.6
464
763
Z01.0
ICD-10 Finland
Examination of eyes and vision
3.8
168.6
848
2747
G04BD09
ATC
trospium; oral
15.7
165.9
280
194
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
16.3
165.6
275
183
G04BD12
ATC
mirabegron; oral
5.5
161.9
525
1093
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
10.4
159.9
329
349
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
6.4
152.8
436
771
34099
ICD-8 Finland
Multiple sclerosis
+∞
152.3
145
*
XKD00
NOMESCO Finland
Uroflowmetry
4.5
141.4
562
1444
L03AB13
ATC
peginterferon beta-1a; parenteral
+∞
140.6
134
*
ZX120
NOMESCO Finland
Intravenous
4.4
139.4
560
1452
N03AX12
ATC
gabapentin; oral
3.4
132.4
763
2688
G04BD04
ATC
oxybutynin; oral, transdermal
6.8
128.8
345
555
N06BA07
ATC
modafinil; oral
50.0
126.1
153
32
N03AE01
ATC
clonazepam; systemic
5.2
119.9
404
863
XKC03
NOMESCO Finland
Water cystometry
8.9
118.0
263
318
H53.2
ICD-10 Finland
Diplopia
8.7
112.4
254
314
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
16.4
112.3
185
119
4AA23
NOMESCO Finland
NA
550.6
108.4
107
*
G37.3
ICD-10 Finland
Acute transverse myelitis in demyelinating disease of central nervous system
+∞
106.8
102
*
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
9.2
105.4
229
264
UKC02
NOMESCO Finland
Cystoscopy
3.4
103.1
564
1875
N31.9
ICD-10 Finland
Neuromuscular dysfunction of bladder, unspecified
26.1
103.0
145
58
R1250
NOMESCO Finland
Evaluation of functional capability
9.4
100.8
216
243
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
4.8
96.9
352
808
H48.1*G35
ICD-10 Finland
Retrobulbar neuritis in multiple sclerosis
+∞
96.3
92
*
NA2CG
NOMESCO Finland
Thoracal spine extensive MRI examination with high intensity magnet
20.6
93.8
142
72
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
3.9
92.2
419
1189
G36.0
ICD-10 Finland
Neuromyelitis optica [Devic]
+∞
88.9
85
*
G97.0
ICD-10 Finland
Cerebrospinal fluid leak from spinal puncture
9.1
88.6
193
223
G04BD07
ATC
tolterodine; oral
5.9
88.5
262
475
NA7BG
NOMESCO Finland
Spine and spinal cord MRI examination with high intensity magnet
24.6
84.7
121
51
N03AX16
ATC
pregabalin; oral
2.4
81.8
883
4403
TKC22
NOMESCO Finland
Catheterisation instruction
10.8
81.8
162
157
L04AA40
ATC
cladribine; oral
+∞
79.5
76
*
G04BD08
ATC
solifenacin; oral
4.4
78.2
303
738
KCV12
NOMESCO Finland
Urinary bladder endoscopic botulin therapy
22.1
73.9
109
51
R90.8
ICD-10 Finland
Other abnormal findings on diagnostic imaging of central nervous system
14.4
72.9
126
91
R35
ICD-10 Finland
Polyuria
4.5
72.7
277
662
SPAT1229
SPAT
Assessment of need for aid
4.0
72.0
313
847
N29
ICPC
Neurological sympt/complt other
9.0
70.9
155
180
H02AB04
ATC
methylprednisolone; systemic
2.6
70.1
600
2616
XCW99
NOMESCO Finland
Other investigative procedure of eye
3.1
68.3
407
1412
L28
ICPC
Limited function/disability (L)
2.7
65.0
487
1959
J01EA01
ATC
trimethoprim; systemic
2.1
64.9
956
5398
G95.8
ICD-10 Finland
Other specified diseases of spinal cord
47.5
64.8
79
17
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.5
63.5
557
2450
R33
ICD-10 Finland
Retention of urine
4.2
63.4
259
660
N28
ICPC
Limited function/disability (N)
10.9
60.7
119
113
G37.2
ICD-10 Finland
Central pontine myelinolysis
+∞
58.5
56
*
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
3.3
57.3
314
1020
O99.3
ICD-10 Finland
Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium
5.7
56.3
170
314
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.0
56.2
921
5367
XCD10
NOMESCO Finland
Electrophysiological examination of eye
6.3
55.8
154
254
N05CF01
ATC
zopiclone; oral
1.9
55.6
995
5992
SPAT1215
SPAT
Assessment of need for medical rehabilitation
4.0
55.4
237
629
TKC20
NOMESCO Finland
Catheterisation of bladder
3.7
55.4
258
737
TAB22
NOMESCO Finland
Stoppin epidural fluid escape with coagulated blood
6.7
55.1
145
224
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.3
54.8
297
956
3419X
ICD-9 Finland
Other demyelinating diseases of central nervous system, Demyelinating disease of central nervous system, unspecified
+∞
54.3
52
*
N32.83
ICD-10 Finland
Nozzle synergy in the bladder neck
35.7
54.3
70
20
36703
ICD-8 Finland
Inflammation of optic nerve and retina, Neuritis optica, retrobulbaris
189.8
54.1
56
*
XKD03
NOMESCO Finland
Urethral pressure profilometry
6.5
53.8
146
235
G04BD11
ATC
fesoterodine; oral
6.2
52.8
147
245
N31.8
ICD-10 Finland
Other neuromuscular dysfunction of bladder
33.0
51.8
68
21
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
3.1
51.4
302
1029
H53.1
ICD-10 Finland
Subjective visual disturbances
3.2
50.8
287
951
N99
ICPC
Neurological disease other
9.8
50.5
104
109
L04AX01
ATC
azathioprine; systemic
3.7
50.3
232
656
G37.8
ICD-10 Finland
Other specified demyelinating diseases of central nervous system
+∞
49.1
47
*
CS444
NOMESCO Finland
Visual field testing with Octopus automated perimetry
5.1
48.6
159
322
G04.9
ICD-10 Finland
Encephalitis, myelitis and encephalomyelitis, unspecified
33.8
48.3
63
19
L01BB04
ATC
cladribine; systemic
+∞
48.0
46
*
R4110
NOMESCO Finland
Physiotherapy
1.9
47.9
834
4918
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
10.8
47.6
93
88
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.3
47.4
476
2217
R4150
NOMESCO Finland
Neuropsychological rehabilitation
10.6
47.1
93
90
H47.2
ICD-10 Finland
Optic atrophy
33.9
46.1
60
18
N39.4
ICD-10 Finland
Other specified urinary incontinence
3.0
45.8
291
1042
SPAT1231
SPAT
Assessment of adjustments needed in living environment
8.8
45.6
100
117
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
3.7
45.6
210
593
R42
ICD-10 Finland
Dizziness and giddiness
2.0
45.1
651
3558
N31.2
ICD-10 Finland
Flaccid neuropathic bladder, not elsewhere classified
12.1
45.0
83
70
N03AF01
ATC
carbamazepine; oral, rectal
3.4
44.4
225
686
N31.1
ICD-10 Finland
Reflex neuropathic bladder, not elsewhere classified
17.0
43.8
70
42
N32.82
ICD-10 Finland
Instability of the detrusor vesicae muscle
9.6
43.3
90
96
34109
ICD-8 Finland
Other demyelinating diseases of central nervous system, Unspecified
+∞
41.7
40
*
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
5.3
41.2
131
257
4AA36
NOMESCO Finland
NA
+∞
40.7
39
*
SPAT1216
SPAT
Assessment of functional ability
2.3
40.2
404
1876
3773B
ICD-9 Finland
Disorders of optic nerve and visual pathways, Optic neuritis[NEURITIS RETROBULBARIS]
402.3
40.2
40
*
R4120
NOMESCO Finland
Occupational therapy
2.9
39.6
256
924
C10AC01
ATC
colestyramine; oral
4.5
39.5
145
332
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
11.3
39.4
75
68
A28
ICPC
Limited function/disability NOS
2.5
39.1
337
1446
AA1AD
NOMESCO Finland
CT of head and brain
1.9
35.6
619
3595
CS494
NOMESCO Finland
Other visual field testing
5.6
35.2
105
192
H49.2
ICD-10 Finland
Sixth [abducent] nerve palsy
12.3
34.7
63
52
H51.2
ICD-10 Finland
Internuclear ophthalmoplegia
93.6
33.8
37
*
H02AB07
ATC
prednisone; oral
2.0
33.5
455
2402
N06AA09
ATC
amitriptyline; systemic
2.3
33.4
332
1526
G50.0
ICD-10 Finland
Trigeminal neuralgia
5.6
33.4
100
184
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.6
33.3
1111
7846
N30.0
ICD-10 Finland
Acute cystitis
2.0
33.1
473
2547
N06AX16
ATC
venlafaxine; oral
1.9
33.0
557
3191
N31.0
ICD-10 Finland
Uninhibited neuropathic bladder, not elsewhere classified
17.0
32.8
52
31
J01CA08
ATC
pivmecillinam; oral
1.6
32.7
1429
10802
RF120
NOMESCO Finland
NA
6.5
32.2
85
133
A02BC02
ATC
pantoprazole; systemic
1.6
32.1
1932
15728
TKC10
NOMESCO Finland
Percutaneous puncture of bladder
10.7
31.4
61
58
N04BD01
ATC
selegiline; oral
8.6
31.4
69
82
N04BC05
ATC
pramipexole; oral
2.7
30.7
223
867
H55
ICD-10 Finland
Nystagmus and other irregular eye movements
15.4
30.4
50
33
R26.8
ICD-10 Finland
Other and unspecified abnormalities of gait and mobility
6.6
30.3
79
122
A06AD11
ATC
lactulose; oral
2.1
30.2
361
1804
U13
ICPC
Bladder symptom/complaint other
4.0
30.0
122
310
N03AF02
ATC
oxcarbazepine; oral
3.4
28.7
142
425
M03BX02
ATC
tizanidine; oral
1.5
28.7
2057
17202
G82.2
ICD-10 Finland
Paraplegia, unspecified
15.4
28.6
47
31
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.2
28.5
320
1555
XF400
NOMESCO Finland
ECG with 12 standard connections
2.0
28.1
412
2232
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
2.6
28.0
208
817
H47.0
ICD-10 Finland
Disorders of optic nerve, not elsewhere classified
16.5
27.5
44
27
N06AX21
ATC
duloxetine; oral
2.0
27.5
397
2137
Z43.5
ICD-10 Finland
Attention to cystostomy
21.3
27.4
40
19
CA1CG
NOMESCO Finland
Eye and orbita extensive MRI examination with high intensity magnet
9.3
26.9
56
61
J01XX05
ATC
methenamine; oral
9.2
26.7
56
62
F02.89
ICD-10 Finland
Dementia in another specified disease that is classified elsewhere without information of additional symptoms
141.1
26.6
28
*
G81.9
ICD-10 Finland
Hemiplegia, unspecified
6.7
26.3
68
104
R03CA02
ATC
ephedrine; oral
52.1
26.2
31
6
H53.4
ICD-10 Finland
Visual field defects
4.9
26.1
87
182
L89
ICD-10 Finland
Decubitus ulcer and pressure area
6.5
25.8
68
107
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.1
25.3
322
1647
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
4.3
25.2
95
225
G04CA02
ATC
tamsulosin; oral
2.0
25.0
353
1883
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
2.6
24.7
185
730
TPH04
NOMESCO Finland
Cathetrisation of vein
1.7
24.5
575
3633
Z01.8
ICD-10 Finland
Other specified special examinations
1.7
24.5
645
4212
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
2.9
24.1
152
542
H48.1
ICD-10 Finland
Retrobulbar neuritis in diseases classified elsewhere
+∞
24.0
23
*
G37.0
ICD-10 Finland
Diffuse sclerosis
+∞
24.0
23
*
SPAT1167
SPAT
Insertion of urinary catheter
4.5
24.0
87
199
Z50.1
ICD-10 Finland
Other physical therapy
2.7
23.9
174
677
N18
ICPC
Paralysis/weakness
5.5
23.2
69
127
J01MA02
ATC
ciprofloxacin; systemic
1.5
23.1
1044
7770
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.0
23.0
324
1722
G36.8
ICD-10 Finland
Other specified acute disseminated demyelination
+∞
22.9
22
*
308
Kela drug reimbursment
Alprostadil, sildenafil and combination product containing aviptadil and phentolamine
8.0
22.9
52
66
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.6
22.9
789
5510
U04
ICPC
Incontinence urine
3.0
22.6
135
462
R39.1
ICD-10 Finland
Other difficulties with micturition
3.8
22.6
97
260
N06AB04
ATC
citalopram; systemic
1.6
22.2
675
4566
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.1
21.7
267
1346
H57.1
ICD-10 Finland
Ocular pain
2.8
21.2
137
494
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
2.0
20.9
286
1503
U07
ICPC
Urine symptom/complaint other
2.5
20.9
171
709
R20.1
ICD-10 Finland
Hypoaesthesia of skin
7.9
20.7
47
60
AA1BM
NOMESCO Finland
MRI examination of brain with 3 Tesla magnet
4.7
20.7
71
154
H53.9
ICD-10 Finland
Visual disturbance, unspecified
3.3
20.7
108
339
RS221
NOMESCO Finland
NA
4.5
20.5
73
165
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.9
20.1
319
1771
A06AC01
ATC
ispaghula (psylla seeds); oral
1.6
20.1
637
4341
G04BD01
ATC
emepronium; systemic
8.5
19.9
43
51
U05
ICPC
Urination problems other
2.9
19.7
125
448
R51.80
ICD-10 Finland
Headache
1.6
19.7
510
3298
U28
ICPC
Limited function/disability (U)
8.8
19.3
41
47
R56.8
ICD-10 Finland
Other and unspecified convulsions
2.4
19.2
161
677
G04BE03
ATC
sildenafil; oral
7.1
18.8
46
66
RF420
NOMESCO Finland
NA
4.2
18.8
72
175
34108
ICD-8 Finland
Other demyelinating diseases of central nervous system, Alii definiti
+∞
18.8
18
*
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
3.1
18.7
103
337
R20.0
ICD-10 Finland
Anaesthesia of skin
6.5
18.5
48
75
RF410
NOMESCO Finland
NA
4.7
18.4
63
137
G04BD10
ATC
darifenacin; oral
9.6
18.3
37
39
119
Kela drug reimbursment
Trigeminal neuralgia or glossofaryngeusneuralgia
12.4
18.1
32
26
G04BDXX
ATC
NA
14.4
18.1
30
21
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.5
18.0
708
5055
H02AB06
ATC
prednisolone; systemic
1.4
17.8
1287
10360
G37.1
ICD-10 Finland
Central demyelination of corpus callosum
+∞
17.7
17
*
Z93.5
ICD-10 Finland
Cystostomy status
67.0
17.7
20
*
G61.0
ICD-10 Finland
Guillain-Barré syndrome
11.1
17.7
33
30
N07AA02
ATC
pyridostigmine; systemic
9.3
17.6
36
39
N06AX11
ATC
mirtazapine; oral
1.4
17.4
916
6945
N87
ICPC
Parkinsonism
7.4
17.4
41
56
6BA02
NOMESCO Finland
NA
10.1
17.4
34
34
XCK10
NOMESCO Finland
Photography of fundus of eye
2.0
17.3
238
1253
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
2.2
17.2
181
853
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.8
17.2
336
1994
G70.0
ICD-10 Finland
Myasthenia gravis
11.1
17.2
32
29
R15
ICD-10 Finland
Faecal incontinence
3.4
17.2
82
242
XX6XT
NOMESCO Finland
Other intravascular therapy with radiological guidance
11.6
17.0
31
27
M05BA04
ATC
alendronic acid; oral
2.3
16.9
156
691
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.4
16.7
1086
8549
H04.10
ICD-10 Finland
Dry eye syndrome
1.8
16.7
297
1712
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.8
16.6
291
1671
R32
ICD-10 Finland
Unspecified urinary incontinence
3.2
16.3
87
279
N02BE01
ATC
paracetamol; systemic, rectal
1.4
16.3
2614
23954
RF432
NOMESCO Finland
NA
40.3
16.3
20
5
N07AA03
ATC
distigmine; systemic
14.3
16.3
27
19
WW400
NOMESCO Finland
Plasmaferesis
14.3
16.3
27
19
NA1CM
NOMESCO Finland
Cervical spine extensive MRI examination with 3 Tesla magnet
14.3
16.3
27
19
H01BA02
ATC
desmopressin; nasal, systemic, sublingual
3.9
16.0
66
173
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.7
15.8
320
1923
RS340
NOMESCO Finland
NA
11.2
15.7
29
26
SPAT1262
SPAT
Handing over of treatment supplies
1.6
15.7
428
2796
N03AX09
ATC
lamotrigine; oral
2.1
15.7
192
965
J01XE01
ATC
nitrofurantoin; oral
3.3
15.6
79
244
U29
ICPC
Urinary symptom/complaint other
3.2
15.6
81
255
J01MA06
ATC
norfloxacin; oral
1.6
15.6
389
2482
359
Kela drug reimbursment
Mirabegroni
8.5
15.4
33
39
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
2.6
15.4
111
432
CS5Z4
NOMESCO Finland
Specialised imaging for glaucoma
4.0
15.2
60
151
G51.0
ICD-10 Finland
Bell palsy
2.9
15.1
92
323
S97
ICPC
Chronic ulcer skin
2.5
14.9
120
497
CS434
NOMESCO Finland
Visual field testing with Humphrey automated perimetry
3.8
14.9
63
169
RS222
NOMESCO Finland
NA
4.4
14.7
53
123
G40.9
ICD-10 Finland
Epilepsy, unspecified
2.5
14.6
111
446
3773A
ICD-9 Finland
Disorders of optic nerve and visual pathways, Optic neuritis[PAPILLITIS OPTICA]
+∞
14.6
14
*
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
3.0
14.6
83
277
G04CA01
ATC
alfuzosin; oral
2.0
14.6
188
965
ABD40
NOMESCO Finland
Implantation of spinal injection device
36.2
14.4
18
5
R27.0
ICD-10 Finland
Ataxia, unspecified
9.4
14.4
29
31
G04BE01
ATC
alprostadil; parenteral, urethral
5.9
14.2
39
67
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
3.6
14.1
63
177
K59.0
ICD-10 Finland
Constipation
2.2
13.9
137
628
H54.2
ICD-10 Finland
Moderate visual impairment, binocular
7.8
13.8
31
40
N06CA01
ATC
amitriptyline and psycholeptics; systemic
1.7
13.7
278
1670
SPAT1221
SPAT
Guidance concerning rehabilitation services and livelihood
3.4
13.7
66
198
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
5.1
13.6
42
83
RS121
NOMESCO Finland
NA
5.7
13.6
38
67
J01MA12
ATC
levofloxacin; systemic
1.5
13.6
437
2966
R13
ICD-10 Finland
Dysphagia
2.1
13.5
158
780
K59.09
ICD-10 Finland
Constipation, unspecified
2.2
13.5
144
684
J01DB01
ATC
cefalexin; oral
1.4
13.4
2530
23270
SPAT1224
SPAT
Implementation of speech therapy rehabilitation plan
4.6
13.4
46
102
K59.00
ICD-10 Finland
Constipation caused by slow bowel passage (SCT)
3.6
13.2
58
162
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.8
13.1
225
1282
N30.9
ICD-10 Finland
Cystitis, unspecified
2.0
13.0
168
863
SPAT1263
SPAT
Sampling
1.3
13.0
1200
9900
G97.1
ICD-10 Finland
Other reaction to spinal and lumbar puncture
10.1
13.0
25
25
R60.0
ICD-10 Finland
Localized oedema
1.8
12.9
245
1441
N06
ICPC
Sensation disturbance other
4.2
12.8
47
112
KA1AE
NOMESCO Finland
Kidney ultrasound examination
3.1
12.8
68
220
RS130
NOMESCO Finland
NA
10.5
12.7
24
23
H30.2
ICD-10 Finland
Posterior cyclitis
9.7
12.7
25
26
R47.1
ICD-10 Finland
Dysarthria and anarthria
6.0
12.7
34
57
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
2.1
12.6
152
759
N02AX02
ATC
tramadol; systemic, rectal
1.3
12.6
1062
8633
XA412
NOMESCO Finland
VEP
70.1
12.6
14
*
108
Kela drug reimbursment
Myasthenia gravis
11.0
12.5
23
21
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.6
12.5
382
2560
G61.8
ICD-10 Finland
Other inflammatory polyneuropathies
20.1
12.4
18
9
U08
ICPC
Urinary retention
4.4
12.3
43
98
Z73.6
ICD-10 Finland
Limitation of activities due to disability
5.9
12.2
33
56
NA1BM
NOMESCO Finland
Cervical spine MRI examination with 3 Tesla magnet
9.7
12.2
24
25
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
2.3
12.2
115
517
SPAT1301
SPAT
No procedures
1.4
12.1
792
6173
N05BA01
ATC
diazepam; systemic, rectal
1.6
12.1
343
2257
R53
ICD-10 Finland
Malaise and fatigue
1.4
12.0
542
3949
U02
ICPC
Urinary frequency/urgency
1.6
12.0
334
2188
N04BA02
ATC
levodopa and decarboxylase inhibitor; oral
3.1
11.9
65
215
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
1.9
11.7
164
868
XA402
NOMESCO Finland
ENMG
2.6
11.7
82
317
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.9
11.6
159
836
SPAT1325
SPAT
Vaccination
1.4
11.6
794
6230
N07AB01
ATC
carbachol; systemic
10.1
11.5
22
22
G04BD
ATC
Drugs for urinary frequency and incontinence
10.1
11.5
22
22
SPAT1293
SPAT
Other function in accordance with rehabilitation guidance nomenclature
5.7
11.5
32
57
ZXA10
NOMESCO Finland
Bilateral
1.5
11.4
427
2995
RF122
NOMESCO Finland
NA
11.8
11.3
20
17
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.3
11.3
1144
9515
36702
ICD-8 Finland
Inflammation of optic nerve and retina, Neuritis optica. Papillitis
35.1
11.3
14
*
G61.9
ICD-10 Finland
Inflammatory polyneuropathy, unspecified
10.6
11.2
21
20
J05AB11
ATC
valaciclovir; oral
1.5
11.2
370
2523
G20
ICD-10 Finland
Parkinson disease
3.1
11.1
60
197
F05
ICPC
Visual disturbance other
2.8
11.1
69
246
KCW98
NOMESCO Finland
Other transluminal endoscopic operation on bladder
20.1
11.1
16
8
SPAT1295
SPAT
Other function in accordance with physical therapy nomenclature
2.0
11.1
136
686
U71
ICPC
Cystitis/urinary infection other
1.9
11.0
168
923
G95.9
ICD-10 Finland
Disease of spinal cord, unspecified
13.9
11.0
18
13
J01MA01
ATC
ofloxacin; systemic
1.8
10.9
202
1181
N03AX14
ATC
levetiracetam; systemic
2.6
10.8
79
311
WX110
NOMESCO Finland
Local anesthesy
1.3
10.7
2121
19227
NA7CM
NOMESCO Finland
Spine and spinal cord extensive MRI examination with 3 Tesla magnet
21.5
10.7
15
7
R5110
SPAT
NA
2.8
10.6
68
250
C03CA01
ATC
furosemide; systemic
1.5
10.6
441
3160
SPAT1260
SPAT
Consultation of another employee
1.5
10.5
437
3127
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
1.6
10.5
280
1814
CA1CM
NOMESCO Finland
Eye and orbita extensive MRI examination with 3 Tesla magnet
10.1
10.5
20
20
CA1BG
NOMESCO Finland
Eye and orbita MRI examination with high intensity magnet
9.2
10.5
21
23
N06AB10
ATC
escitalopram; oral
1.4
10.5
650
5010
H52.1
ICD-10 Finland
Myopia
2.1
10.4
113
541
G36.1
ICD-10 Finland
Acute and subacute haemorrhagic leukoencephalitis [Hurst]
+∞
10.4
10
*
R5599
NOMESCO Finland
Other rehabilitation service
2.5
10.3
80
327
G96.9
ICD-10 Finland
Disorder of central nervous system, unspecified
18.8
10.2
15
8
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.3
10.2
1654
14571
R52.2
ICD-10 Finland
Other chronic pain
2.2
10.2
97
441
G83.1
ICD-10 Finland
Monoplegia of lower limb
13.1
10.1
17
13
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.3
10.1
980
8080
WX892
NOMESCO Finland
Monitored bed care
1.8
10.0
160
892
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.5
10.0
391
2765
7819X
ICD-9 Finland
Symptoms involving nervous and musculoskeletal systems, Other symptoms involving nervous and musculoskeletal systems[SYMPTOMATA ALIA SYSTEMATIS NERVORUM ET MUSCULOSCEL]
4.4
10.0
35
81
M48.0
ICD-10 Finland
Spinal stenosis
1.7
9.8
211
1289
AAH30
NOMESCO Finland
Thermal destruction of cranial nerve
26.1
9.8
13
5
R31
ICD-10 Finland
Unspecified haematuria
1.8
9.6
171
987
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.8
9.5
163
929
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.3
9.5
775
6219
XF600
NOMESCO Finland
Bloodpressure measurement
1.9
9.5
142
776
G04.0
ICD-10 Finland
Acute disseminated encephalitis
100.3
9.4
10
*
G04.8
ICD-10 Finland
Other encephalitis, myelitis and encephalomyelitis
17.6
9.4
14
8
3418X
ICD-9 Finland
Other demyelinating diseases of central nervous system
+∞
9.4
9
*
L17
ICPC
Foot/toe symptom/complaint
1.4
9.1
601
4667
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
2.3
9.1
78
338
W19
ICD-10 Finland
Unspecified fall
1.6
9.0
208
1296
SPAT1234
SPAT
Support of social functional capacity
2.0
9.0
105
523
RF210
NOMESCO Finland
NA
2.2
9.0
88
405
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.7
9.0
199
1227
R2120
NOMESCO Finland
Counselling and guidance concerning rehabilitation services and social security
4.2
9.0
32
76
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
2.6
9.0
63
247
J05AB01
ATC
aciclovir; systemic
1.4
8.9
586
4543
G44.2
ICD-10 Finland
Tension-type headache
1.4
8.9
391
2823
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.5
8.9
305
2093
N04BA03
ATC
levodopa, decarboxylase inhibitor and COMT inhibitor; oral
5.7
8.9
24
42
RF312
NOMESCO Finland
NA
12.5
8.9
15
12
SPAT1254
SPAT
Administration of medicine
1.5
8.8
319
2220
CS424
NOMESCO Finland
Visual field testing with Goldmann perimetry
4.6
8.8
29
64
N27
ICPC
Fear of neurological disease other
3.8
8.7
35
93
WX408
NOMESCO Finland
General anesthesy, balanced
1.3
8.6
674
5368
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
2.5
8.5
62
246
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.2
8.5
1769
15908
G11.9
ICD-10 Finland
Hereditary ataxia, unspecified
12.8
8.4
14
11
G37.5
ICD-10 Finland
Concentric sclerosis [Baló]
+∞
8.3
8
*
R1260
NOMESCO Finland
Evaluation of communicative skills
3.4
8.3
38
113
H49.0
ICD-10 Finland
Third [oculomotor] nerve palsy
7.1
8.2
19
27
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
3.5
8.2
36
103
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
2.5
8.2
60
239
ABD30
NOMESCO Finland
Implantation of spinal stimulation device
3.7
8.2
34
93
R11
ICD-10 Finland
Nausea and vomiting
1.6
8.2
196
1238
Z02.4
ICD-10 Finland
Examination for driving licence
0.6
8.1
161
2476
RF310
NOMESCO Finland
NA
6.0
8.1
21
35
A02BA02
ATC
ranitidine; systemic
1.4
8.1
441
3315
SPAT1296
SPAT
Other function in accordance with occupational therapy nomenclature
3.4
8.1
37
110
NA1AG
NOMESCO Finland
Restricted MRI of cervical spine
33.4
8.1
10
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.3
8.0
880
7322
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
1.8
8.0
126
699
H57.9
ICD-10 Finland
Disorder of eye and adnexa, unspecified
3.6
8.0
34
95
G04BE08
ATC
tadalafil; oral
22.1
8.0
11
5
1DB07
NOMESCO Finland
NA
22.1
8.0
11
5
TAW99
NOMESCO Finland
Other minor neurosurgical procedure
5.3
8.0
23
44
XKX00
NOMESCO Finland
Pelvic floor electromyography
6.1
7.8
20
33
M54.1
ICD-10 Finland
Radiculopathy
1.9
7.8
102
533
JC2KB
NOMESCO Finland
Functional X-ray examination of swallowing
3.5
7.8
34
98
D21
ICPC
Swallowing problem
3.8
7.7
31
83
TKC10
SPAT
NA
45.1
7.7
9
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.4
7.7
436
3301
A29
ICPC
General symptom/complaint other
1.5
7.7
238
1602
SPAT1281
SPAT
Other administrative function
1.6
7.6
203
1315
M05BB03
ATC
alendronic acid and colecalciferol; oral
3.1
7.6
40
132
H53.8
ICD-10 Finland
Other visual disturbances
3.4
7.6
35
105
SAA03
NOMESCO Finland
Extended examination of mouth
1.2
7.6
1129
9731
R25.2
ICD-10 Finland
Cramp and spasm
2.5
7.6
57
233
G57.3
ICD-10 Finland
Lesion of lateral popliteal nerve
2.9
7.6
42
144
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.2
7.6
1450
12854
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.4
7.6
313
2235
G83.9
ICD-10 Finland
Paralytic syndrome, unspecified
10.0
7.5
14
14
RS142
NOMESCO Finland
NA
7.1
7.5
17
24
R83.4
ICD-10 Finland
Abnormal findings in cerebrospinal fluid, Abnormal immunological findings
80.3
7.4
8
*
1601
FHL
Cystometry
80.3
7.4
8
*
SAA01
NOMESCO Finland
Simple examination of mouth
1.2
7.4
2194
20344
M05BX04
ATC
denosumab; parenteral
2.1
7.4
84
415
J01AA02
ATC
doxycycline; systemic
1.2
7.4
2275
21181
RS230
NOMESCO Finland
NA
4.6
7.4
24
53
H50.52
ICD-10 Finland
Exophoria
3.0
7.3
40
136
M79.6
ICD-10 Finland
Pain in limb
1.3
7.3
941
7970
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
1.7
7.3
148
892
N30.1
ICD-10 Finland
Interstitial cystitis (chronic)
3.4
7.3
33
98
4AA34
NOMESCO Finland
NA
+∞
7.3
7
*
H01AA02
ATC
tetracosactide; parenteral
+∞
7.3
7
*
A41.9
ICD-10 Finland
Sepsis, unspecified
2.3
7.3
66
295
J01DA01
ATC
[U] cefalexin; systemic
1.2
7.3
1836
16723
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.2
7.2
1019
8722
SAA02
NOMESCO Finland
Basic examination of mouth
1.2
7.2
1999
18379
A06AC51
ATC
ispaghula, combinations; systemic
1.8
7.2
113
629
H05BA01
ATC
calcitonin (salmon synthetic); nasal, parenteral
2.6
7.1
47
180
R26.0
ICD-10 Finland
Ataxic gait
7.9
7.1
15
19
K02.1
ICD-10 Finland
Caries of dentine
1.2
7.1
1735
15730
XX1ZW
NOMESCO Finland
Very extensive written report from radiologist
5.3
7.1
20
38
L19
ICPC
Muscle symptom/complaint NOS
2.3
7.0
62
275
RF214
NOMESCO Finland
NA
10.0
7.0
13
13
E0000UV
ATC
NA
1.2
6.9
1094
9472
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.3
6.9
842
7079
XX1XW
NOMESCO Finland
Extensive written report from radiologist
2.4
6.9
55
232
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.3
6.9
434
3336
R30.0
ICD-10 Finland
Dysuria
1.9
6.9
91
479
D82
ICPC
Teeth/gum disease
1.2
6.8
1017
8744
D17
ICPC
Incontinence of bowel
4.8
6.8
21
44
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
1.6
6.8
188
1231
KCE02
NOMESCO Finland
Transluminal endoscopic extraction of calculus from bladder
6.7
6.8
16
24
R4130
NOMESCO Finland
Speech therapy
2.4
6.8
52
216
SPAT1172
SPAT
Guidance concerning hydration
2.8
6.8
40
143
34409
ICD-8 Finland
Other cerebral paralysis, Unspecified
40.1
6.8
8
*
A46
ICD-10 Finland
Erysipelas
1.5
6.7
246
1717
SPAT1104
SPAT
Monitoring of emergency patient
1.7
6.7
141
860
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.3
6.7
433
3339
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.4
6.7
338
2502
K59.01
ICD-10 Finland
Constipation outlet obstruction type
3.2
6.7
33
105
K07
ICPC
Swollen ankles/oedema
2.0
6.7
75
371
78050
ICD-8 Finland
Certain symptoms referable to nervous system and special senses, Vertigo
4.1
6.7
24
59
H81.4
ICD-10 Finland
Vertigo of central origin
4.4
6.6
22
50
H20.1
ICD-10 Finland
Chronic iridocyclitis
3.1
6.6
34
112
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
1.8
6.6
101
561
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.4
6.6
276
1978
R30.1
ICD-10 Finland
Vesical tenesmus
2.6
6.6
44
170
R20.8
ICD-10 Finland
Other and unspecified disturbances of skin sensation
3.0
6.6
35
118
TNX34
NOMESCO Finland
Major custom molded cast, unspecified region
2.6
6.5
44
171
U01
ICPC
Dysuria/painful urination
1.5
6.5
188
1244
SPAT1211
SPAT
Application of soft bandage
1.5
6.5
194
1297
W10
ICD-10 Finland
Fall on and from stairs and steps
1.8
6.5
111
639
F43.29
ICD-10 Finland
Adaptation disorder UNS
2.0
6.5
75
375
XKW99
NOMESCO Finland
Other physiological examination of urinary or male genital system
3.8
6.5
25
66
L29
ICPC
Musculoskeletal sympt/complt other
1.6
6.4
173
1126
R06.0
ICD-10 Finland
Dyspnoea
1.3
6.4
525
4192
E87.6
ICD-10 Finland
Hypokalaemia
2.1
6.4
66
316
B02.9
ICD-10 Finland
Zoster without complication
1.8
6.4
108
618
MA3AE
NOMESCO Finland
Combined first trimester screening
0.5
6.4
41
848
N86
ICD-10 Finland
Erosion and ectropion of cervix uteri
4.9
6.3
19
39
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
1.9
6.3
85
452
A04AA55
ATC
palonosetron, combinations; systemic
0.3
6.3
15
460
183
Kela drug reimbursment
Lamotrigin and topiramate
2.8
6.3
37
132
Z01.2
ICD-10 Finland
Dental examination
1.2
6.3
1198
10552
RF433
NOMESCO Finland
NA
9.3
6.3
12
13
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
2.0
6.3
78
402
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.2
6.3
1556
14059
N30
ICD-10 Finland
Cystitis
1.5
6.2
198
1341
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.4
6.2
259
1855
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
1.6
6.2
144
907
U07.2
ICD-10 Finland
COVID-19, virus not identified
0.8
6.2
383
4860
H52.2
ICD-10 Finland
Astigmatism
2.5
6.1
42
166
SPAT1360
SPAT
Extensive global examination
1.6
6.1
154
988
110
Kela drug reimbursment
Parkinson's disease and comparable movement disrorders
2.5
6.1
45
185
N30.8
ICD-10 Finland
Other cystitis
3.5
6.1
26
75
A02BA04
ATC
nizatidine; systemic
1.6
6.1
149
948
N39.9
ICD-10 Finland
Disorder of urinary system, unspecified
2.6
6.1
40
153
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
1.2
6.1
1615
14665
34400
ICD-8 Finland
Other cerebral paralysis, Hemiplegia NUD
12.5
6.1
10
8
U72
ICPC
Urethritis
2.2
6.1
59
277
N02AA05
ATC
oxycodone; systemic
1.4
6.1
247
1762
L02.3
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of buttock
2.2
6.1
58
269
A08
ICPC
Swelling
1.9
6.0
78
407
T83.0
ICD-10 Finland
Mechanical complication of urinary (indwelling) catheter
10.0
6.0
11
11
KH1AT
NOMESCO Finland
Urinary tract cathetrisation with ultrasound guidance
10.0
6.0
11
11
M01AE01
ATC
ibuprofen; systemic, rectal
1.3
6.0
2862
27555
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
2.3
6.0
50
218
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
261
160
17.49
313.16
1.1
1.1
miu/ml
1695.1
1539.7
0.78
261
160
(3022096) Basophils/100 leukocytes in Blood
2512
13437
3.79
309.69
12.6
5.9
%
0.8
0.7
10.43
2459
12599
(3013115) Eosinophils [#/volume] in Blood
2729
15438
4.04
308.05
13.0
6.0
e9/l
0.2
0.2
0.11
2541
13809
(3016018) Differential panel - Cerebral spinal fluid
352
308
12.54
307.65
1.1
1.4
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
770
731
13.08
307.65
1.2
1.3
mg/l
426.9
503.8
3.26
742
691
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
367
198
20.50
307.65
2.8
1.9
%
15.1
12.5
2.11
179
98
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
286
191
16.16
307.65
4.5
2.3
e6/l
976.0
716.1
3.36
186
67
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
727
485
18.47
307.65
1.2
1.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
708
460
18.85
307.65
1.2
1.2
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
437
252
19.56
307.65
3.8
2.1
e9/l
1.2
1.3
0.15
209
155
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
684
224
37.35
307.65
1.1
1.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
581
290
23.64
307.65
1.1
1.1
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
1190
2208
7.51
307.65
3.5
2.6
g/l
10.0
10.6
6.20
1088
2037
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
461
179
29.33
307.65
1.1
1.1
u/l
1.0
1.0
0.86
182
82
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
623
660
11.18
307.65
1.1
1.3
mmol/l
3.6
3.7
1.90
580
619
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
362
174
22.99
307.65
4.2
2.0
e9/l
0.3
0.2
1.84
317
145
(42870588) Differential panel, method unspecified - Blood
2129
9518
3.97
307.65
11.2
5.8
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
766
1711
5.40
307.65
3.5
1.7
g/l
1.1
1.4
4.11
751
1587
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
249
55
48.51
307.65
1.0
1.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
678
592
13.84
307.65
1.2
1.4
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
2703
14893
4.14
307.65
13.0
5.8
e9/l
0.0
0.0
0.47
2509
13065
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
641
645
11.84
307.65
1.2
1.4
e6/l
31.5
25.9
0.10
509
488
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
476
12
456.00
307.65
2.8
1.1
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
335
221
16.59
307.65
2.6
2.2
%
48.9
40.7
1.30
110
20
(4027681)
557
191
34.23
307.65
1.3
1.2
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
212
20
112.47
307.65
1.1
1.0
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
364
179
22.48
307.65
4.1
2.0
e6/l
470.8
602.9
1.45
315
144
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
640
645
11.82
307.65
1.2
1.4
e6/l
514.6
1404.2
0.92
524
516
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
634
979
7.63
307.65
1.9
1.6
iu/ml
52.2
0.4
0.59
47
200
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
672
230
35.58
307.65
1.1
1.1
mg/l
217.5
238.1
1.06
589
200
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
378
32
131.66
307.65
1.2
1.1
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
2702
14845
4.16
307.65
12.9
5.8
e9/l
0.6
0.5
0.40
2505
13043
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
686
242
34.68
307.65
1.2
1.2
mg/l
53.4
34.1
9.71
562
207
(3019198) Lymphocytes [#/volume] in Blood
2711
15366
3.97
302.75
12.9
5.8
e9/l
1.7
2.0
10.44
2534
13784
(3019069) Monocytes/100 leukocytes in Blood
2555
13987
3.76
299.88
12.7
6.1
%
9.0
8.2
43.98
2503
13196
(3006504) Eosinophils/100 leukocytes in Blood
2543
13902
3.73
298.60
12.6
5.8
%
3.0
2.8
4.96
2490
13017
(3000060) B lymphocytes [#/volume] in Blood
201
76
27.93
295.24
3.1
1.7
e6/l
53.5
173.5
3.91
89
40
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
271
200
14.56
294.28
3.0
2.0
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
190
68
29.42
284.26
4.7
2.5
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
313
311
10.91
281.47
1.2
1.6
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
2574
14503
3.63
280.78
12.6
5.9
%
26.4
29.2
34.95
2515
13627
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
793
2078
4.60
280.09
1.4
1.3
au/ml
19.1
43.0
—
9
96
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
828
2259
4.45
277.39
2.5
2.4
au/ml
40.1
22.6
1.55
21
175
(3018010) Neutrophils/100 leukocytes in Blood
2543
14313
3.56
275.80
12.2
5.7
%
58.9
56.6
20.71
2487
13492
(21494814) CD8 cells/100 lymphocytes in Specimen
193
94
21.62
256.98
2.2
2.0
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
2776
17078
3.61
248.25
14.0
8.8
e9/l
3.7
4.0
10.32
2582
15057
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
237
223
11.30
220.60
1.1
1.4
mmol/l
1.7
2.0
3.81
222
205
(3002582) Erythrocytes [#/volume] in Urine
1618
7832
2.91
210.74
4.9
2.9
e6/l
21.2
95.8
3.21
1377
5911
(3000850) Epithelial cells [#/volume] in Urine
1265
5415
3.04
205.39
3.6
2.4
e6/l
4.9
7.0
8.08
1167
4737
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
2153
12233
2.85
204.66
2.5
2.2
nmol/l
89.7
74.6
73.14
2021
11305
(3030467) Casts [#/volume] in Urine by Automated count
1504
7126
2.89
202.04
4.6
2.8
e6/l
0.2
0.3
6.88
1250
5286
(36304419) Bacteria [Presence] in Urine
1491
7102
2.86
197.31
4.5
2.7
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
1770
9561
2.65
178.18
5.8
3.4
e6/l
76.7
78.2
0.03
1427
6489
(3026782) Osmolality of Urine
1141
5009
2.86
172.09
3.7
2.6
mosm/kgh2o
548.0
541.9
0.42
1041
4276
(3031040) Bacteria [#/volume] in Urine by Automated count
2778
19082
2.91
166.30
8.3
3.9
e6/l
2712.5
1537.3
0.30
37
224
(3026008) Bacteria identified in Urine by Culture
1480
7707
2.55
155.48
4.6
2.6
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
2104
13191
2.40
142.60
13.8
8.5
e9/l
0.0
0.0
0.12
1827
10827
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
152
142
11.13
141.66
1.1
1.3
%
94.8
66.6
2.71
21
16
(3037467) Urinalysis macro (dipstick) panel - Urine
2816
20256
2.71
139.54
7.7
3.9
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
726
2859
2.92
129.98
1.3
1.5
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
917
4256
2.54
117.56
4.2
2.5
e6/l
0.9
1.2
1.00
556
2316
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
419
1280
3.57
114.04
1.5
2.1
u/l
36.2
39.6
3.11
394
1174
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
105
81
13.32
110.33
1.1
1.2
%
3.8
15.1
—
18
10
(3035350) Ketones [Presence] in Urine by Test strip
2139
14505
2.15
106.91
5.9
3.3
estimate
0.0
0.0
1.08
507
2691
(3024561) Albumin [Mass/volume] in Serum or Plasma
1761
11117
2.13
105.92
4.1
4.6
g/l
37.1
36.4
6.38
1644
10397
(3009261) Glucose [Presence] in Urine by Test strip
2155
14708
2.14
105.21
6.0
3.3
estimate
0.0
0.0
1.32
517
2693
(3021601) Nitrite [Presence] in Urine by Test strip
2141
14590
2.13
104.77
7.9
4.5
estimate
0.0
0.0
0.37
519
2780
(3015736) pH of Urine
1763
11180
2.12
104.26
5.0
3.1
—
5.8
—
0
9
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
136
173
8.13
100.29
4.1
2.7
%
48.7
43.6
1.44
55
52
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
828
3985
2.39
95.74
4.4
2.6
e6/l
5.0
3.4
1.98
467
2054
(3017181) Myelocytes/100 leukocytes in Blood
566
2326
2.70
91.05
5.7
4.3
%
0.6
0.8
1.13
124
595
(3002179) Metamyelocytes/100 leukocytes in Blood
531
2128
2.75
89.65
5.6
4.1
%
0.2
0.6
3.83
97
445
(3025159) Blasts/100 leukocytes in Blood
525
2109
2.74
88.14
5.8
4.4
%
0.0
0.4
0.95
103
464
(3021440) Promyelocytes/100 leukocytes in Blood
538
2220
2.67
85.52
5.9
4.3
%
0.1
0.1
1.60
115
549
(3017143) Hepatitis C virus Ab [Presence] in Serum
842
4389
2.19
78.72
1.5
1.6
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
101
136
7.61
70.87
1.2
1.7
—
—
—
0
0
(40758558) Short blood count panel - Blood
1208
7426
1.94
70.59
8.7
6.6
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1967
14178
1.84
69.06
5.4
5.9
umol/l
9.8
10.6
4.21
1885
13442
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
89
108
8.42
68.13
1.1
1.1
ng/l
117.5
465.8
0.78
30
20
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
79
83
9.71
67.57
2.0
2.1
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
1181
7318
1.91
66.58
9.6
4.2
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
207
565
3.82
65.82
4.2
3.8
%
60.4
56.9
3.71
207
565
(3018677) aPTT in Platelet poor plasma by Coagulation assay
717
3757
2.13
64.75
1.9
2.2
s
29.2
29.4
0.71
688
3636
(3020630) Protein [Mass/volume] in Serum or Plasma
409
1704
2.58
62.80
1.6
2.5
g/l
68.3
67.1
2.90
385
1574
(3011397) Hemoglobin [Presence] in Urine by Test strip
1072
6538
1.91
62.74
5.1
3.3
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
99
154
6.58
60.89
1.1
1.1
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
1069
6596
1.88
59.84
1.6
1.7
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
1062
6622
1.85
57.01
2.4
1.4
g/l
2.0
2.2
5.25
798
4245
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
350
1456
2.55
53.61
2.6
1.7
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
1159
7563
1.78
52.73
2.3
2.1
u/l
149.3
212.2
1.93
1104
7167
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
94
162
5.93
52.23
1.1
1.1
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
231
791
3.05
51.22
1.3
1.2
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
2059
15832
1.69
50.73
4.6
4.4
mmol/l
6.2
6.5
9.41
1941
14581
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
2624
21805
1.72
45.80
7.0
7.1
u/l
74.1
74.7
0.29
2476
20642
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
426
2110
2.15
43.28
2.6
2.2
u/l
2473.3
5080.6
1.06
106
864
(3029937) Albumin [Presence] in Urine by Test strip
1124
7652
1.68
41.88
7.2
3.6
estimate
0.0
0.0
1.49
515
2735
(46235355) HIV 1 and 2 tests - Meaningful Use set
1165
8009
1.67
41.79
1.8
1.9
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
282
1196
2.47
41.19
1.4
1.3
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
108
262
4.22
40.33
1.2
1.6
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
49
55
9.02
39.84
1.1
1.3
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
1540
11469
1.59
39.27
6.7
3.3
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
58
83
7.08
38.55
1.1
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
58
83
7.08
38.55
1.1
1.1
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
1191
8374
1.63
38.36
5.8
2.8
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
57
85
6.80
36.49
1.1
1.1
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
62
104
6.05
35.43
1.0
1.0
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
457
2537
1.92
33.40
7.0
3.4
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
3340
30620
2.07
33.11
15.5
11.6
mg/l
20.7
20.6
0.12
2623
23841
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
93
234
4.05
33.11
1.2
1.6
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
1288
9529
1.54
31.93
6.5
6.9
inr
1.1
1.1
0.92
414
2957
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
51
81
6.37
30.77
1.1
1.1
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
1612
12625
1.50
29.94
6.1
6.2
mmol/l
1.2
1.2
2.52
1315
10727
(3037522) Nuclear Ab [Titer] in Serum
712
4637
1.67
29.91
1.4
1.4
titre
400.0
549.3
2.86
171
931
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
51
85
6.07
29.35
1.1
1.1
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2548
21974
1.53
29.03
4.4
2.9
u/l
43.3
41.0
0.69
2443
20912
(3023511) Choriogonadotropin [Units/volume] in Urine
243
1125
2.24
28.91
1.6
1.3
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
3470
32552
2.34
28.06
15.6
9.1
u/l
26.7
26.2
0.85
3397
31651
(3019550) Sodium [Moles/volume] in Serum or Plasma
3285
30240
1.86
27.77
15.1
12.1
mmol/l
139.6
139.7
0.07
3219
29483
(3004588) Protein electrophoresis panel - Serum or Plasma
276
1381
2.08
26.93
1.8
2.2
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
3291
30363
1.85
26.90
15.2
12.2
mmol/l
3.9
3.9
3.95
3217
29540
(3030981) Hyaline casts [#/volume] in Urine by Automated count
257
1255
2.13
26.73
5.0
2.5
e6/l
0.2
0.3
0.07
252
1209
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
51
95
5.43
26.16
1.1
1.2
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
880
6220
1.55
25.76
5.1
4.1
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1330
10239
1.47
25.75
4.0
3.2
u/l
29.9
31.4
0.82
1288
9769
(3033658) Prothrombin time (PT) actual/Normal
972
7052
1.52
25.10
4.1
3.7
%
96.7
95.3
1.14
950
6861
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
1439
11344
1.44
24.15
5.6
5.6
mmol/l
1.2
1.2
1.17
1294
10361
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
577
3743
1.64
24.13
1.9
1.8
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
1319
10236
1.45
24.05
1.9
1.8
pmol/l
95.5
98.0
1.11
684
5479
(3002385) Erythrocyte distribution width [Ratio]
2920
26375
1.54
22.90
22.1
13.9
%
13.4
13.5
3.33
2882
25844
(3052851) Hemolysis interference index of Serum or Plasma
175
784
2.29
22.50
2.2
3.0
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
2764
30070
0.67
22.43
3.8
3.8
mmol/l
1.5
1.5
0.04
2536
28409
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
31
41
7.62
22.07
1.1
1.0
—
—
—
0
0
(3018418) pH of Serum or Plasma
1001
7486
1.46
21.67
3.5
3.8
ph
7.4
7.4
0.23
200
1419
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
111
410
2.76
21.46
1.2
1.8
—
1200.0
—
0
14
(3013707) Erythrocyte sedimentation rate by Westergren method
2506
22065
1.43
21.44
3.7
3.9
mm/h
10.3
10.3
0.10
2338
20711
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
191
907
2.17
21.32
1.6
1.6
titre
87.7
363.4
1.56
11
35
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
30
41
7.37
20.77
1.1
1.0
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
2831
30531
0.68
19.97
4.1
4.1
mmol/l
2.9
2.9
0.73
2592
28762
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
2796
30210
0.68
19.70
3.8
3.8
mmol/l
4.8
4.8
1.14
2587
28647
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
2660
28993
0.70
19.55
3.4
3.5
mmol/l
1.3
1.3
0.24
2447
27309
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
3085
28453
1.54
19.43
13.6
10.1
ml/min/173m2
93.4
88.4
36.92
2652
23456
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
78
256
3.09
18.68
1.1
1.2
—
—
—
0
0
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
27
38
7.15
18.22
1.1
1.1
%
91.4
46.6
3.59
17
15
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
48
117
4.14
17.94
1.1
1.2
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
246
1371
1.85
17.47
1.2
1.3
u/ml
4.4
0.9
0.68
11
119
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
23
31
7.46
16.10
1.0
1.1
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
1009
12573
0.73
15.85
2.4
2.4
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
736
5488
1.43
15.40
1.6
1.5
nmol/l
20.4
20.7
0.16
641
4814
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
384
2509
1.59
15.22
1.7
1.7
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
156
784
2.03
15.05
1.6
2.1
g/l
7.0
7.3
1.57
120
599
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
156
784
2.03
15.05
1.6
2.1
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
150
746
2.05
14.90
1.5
2.1
g/l
2.9
3.1
1.66
117
582
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
155
783
2.02
14.75
1.6
2.1
g/l
3.5
3.8
2.05
116
565
(40761535) Cells panel - Urine sediment
326
2067
1.63
14.61
6.1
3.3
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
144
711
2.07
14.59
1.6
2.2
g/l
10.0
10.4
0.39
123
616
(3019309) Folate [Moles/volume] in Red Blood Cells
576
4151
1.46
14.39
1.7
1.7
nmol/l
1087.4
1178.6
1.34
439
3221
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
25
42
5.99
14.31
1.0
1.2
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
59
194
3.07
14.17
1.0
1.1
nmol/l
4.3
6.2
—
10
32
(3024139) IgG subclass 3 [Mass/volume] in Serum
82
323
2.57
14.08
1.4
1.4
g/l
0.3
0.4
1.53
56
223
(3028192) IgG subclass 2 [Mass/volume] in Serum
82
323
2.57
14.08
1.4
1.4
g/l
2.8
3.0
0.24
57
225
(3027135) IgG subclass 1 [Mass/volume] in Serum
82
324
2.57
13.99
1.4
1.4
g/l
6.3
6.6
0.27
57
226
(3008757) Leukocyte morphology finding [Identifier] in Blood
68
246
2.80
13.79
3.2
3.4
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
814
6281
1.38
13.76
6.5
3.5
kg/l
1.0
1.0
0.06
117
905
(4062490)
82
327
2.54
13.74
1.5
1.4
—
—
—
0
0
(3013512) EKG study
889
6962
1.37
13.70
3.4
3.2
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
382
2555
1.55
13.64
1.8
1.7
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
338
2198
1.59
13.64
2.6
2.5
e9/l
4.1
4.1
0.09
285
1834
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
155
826
1.92
12.69
1.5
2.1
mg/l
9.1
10.9
2.52
148
772
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
211
1238
1.75
12.64
1.6
1.6
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
3037
28454
1.40
12.64
5.4
4.8
mu/l
1.7
2.0
2.08
2835
26752
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
1140
9364
1.32
12.51
3.3
3.0
ng/l
33.4
39.7
0.29
665
5075
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
123
612
2.05
12.25
1.6
2.1
g/l
39.4
38.2
1.26
109
540
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
17
23
7.42
11.84
1.1
1.0
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
299
4419
0.65
11.52
1.3
1.3
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
82
356
2.33
11.49
3.0
3.1
%
0.6
1.5
4.35
70
290
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
113
559
2.05
11.46
1.6
2.2
g/l
0.0
0.0
0.00
104
520
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
120
607
2.01
11.45
1.6
2.1
g/l
0.0
0.0
0.65
111
566
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
178
1026
1.77
11.36
1.8
1.8
g/l
1.2
1.2
0.11
171
965
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
173
993
1.78
11.21
1.8
1.9
g/l
0.2
0.2
0.25
166
934
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
112
557
2.04
11.20
1.6
2.2
g/l
0.0
0.0
0.00
104
519
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
19
31
6.16
11.19
1.1
1.2
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
181
1056
1.75
11.09
2.1
2.0
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
128
671
1.94
11.04
1.6
2.3
g/l
0.5
0.8
0.53
115
601
(3032352) Blasts [#/volume] in Cerebral spinal fluid
16
23
6.98
10.57
1.2
3.0
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
158
899
1.79
10.56
2.0
1.8
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
104
522
2.02
10.18
1.5
1.7
g/l
0.6
0.7
0.93
75
400
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
15
21
7.17
10.13
1.1
1.0
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
1067
8894
1.28
10.01
2.6
3.2
mmol/l
2.3
2.3
0.24
922
7989
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
32
90
3.58
9.91
3.2
2.7
umol/l
23.4
30.1
1.80
22
66
(3001019) Free T4 and TSH panel - Serum or Plasma
156
2580
0.59
9.68
1.6
1.7
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
260
3766
0.67
8.97
1.6
1.6
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
23
55
4.20
8.91
1.1
1.2
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
53
214
2.50
8.78
2.9
2.9
%
50.2
55.1
0.78
39
148
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
163
994
1.67
8.57
1.2
1.2
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
1036
8742
1.26
8.52
2.4
2.5
u/l
52.1
56.5
4.57
957
8145
(3016650) Hepatitis A virus Ab [Presence] in Serum
107
578
1.88
8.52
1.1
1.1
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
147
874
1.71
8.49
1.3
1.3
titre
108.9
181.2
0.46
18
83
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
289
2016
1.47
8.42
3.9
3.5
mmol/l
1.2
1.2
0.32
249
1755
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
49
195
2.53
8.38
1.3
1.1
u/ml
1.6
29.4
—
8
18
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
93
482
1.95
8.38
1.3
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
93
482
1.95
8.38
1.3
1.3
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
20
45
4.46
8.36
1.5
1.9
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
19
41
4.65
8.34
1.1
1.2
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
191
1225
1.59
8.21
6.0
3.0
—
—
—
0
0
(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum
14
23
6.11
8.18
1.5
1.6
mg/l
1.5
0.8
—
8
14
(3045414) Leukocytes [Presence] in Urine
203
1324
1.56
8.13
1.8
1.8
—
—
—
0
0
(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid
14
24
5.85
7.85
1.1
1.0
%
4.8
21.6
—
6
5
(40761511) CBC panel - Blood by Automated count
3356
32443
1.43
7.78
14.8
10.7
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
380
2846
1.37
7.44
7.4
7.3
mmol/l
104.2
104.6
0.70
363
2782
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
427
3263
1.35
7.35
2.8
2.7
umol/l
6.3
7.2
0.64
372
2808
(40761539) Cells [Type] in Urine sediment by Light microscopy
22
59
3.75
7.34
1.8
1.2
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
158
998
1.61
7.28
2.2
1.9
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
517
4078
1.31
7.14
3.3
3.5
mmol/l
0.8
0.8
0.31
476
3839
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
24
70
3.44
7.11
1.0
1.1
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
25
75
3.35
7.10
1.2
1.1
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
25
75
3.35
7.10
1.2
1.1
%
88.9
97.0
0.59
25
75
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
80
421
1.92
6.96
1.4
1.4
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
34
125
2.74
6.85
1.1
1.1
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
153
974
1.60
6.84
1.2
1.3
u/ml
29.2
37.5
—
8
68
(3022621) pH of Urine by Test strip
260
1853
1.43
6.80
4.3
2.5
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
250
1770
1.44
6.77
1.8
1.6
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
26
83
3.15
6.70
1.1
1.1
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
342
4495
0.74
6.67
1.4
1.4
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
341
2559
1.37
6.59
2.9
4.3
u/l
226.7
240.4
1.15
322
2431
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
127
781
1.65
6.54
2.0
2.4
ug/l
245.9
342.9
0.58
118
714
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
219
1527
1.46
6.44
1.2
1.3
miu/ml
192.9
226.4
0.74
82
775
(3051611) Lipemic interference index of Serum or Plasma
54
254
2.14
6.41
1.6
3.3
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
337
2536
1.36
6.41
3.8
2.8
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
20
56
3.59
6.31
1.2
1.2
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
666
5514
1.25
6.21
1.6
1.6
pmol/l
15817676.9
35278379.9
0.56
569
4731
(3027945) Reticulocytes/100 erythrocytes in Blood
321
2409
1.36
6.21
3.3
2.6
%
1.6
1.8
3.23
279
2151
(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum
12
23
5.23
6.00
1.4
1.6
mg/l
3.5
6.1
—
7
12
(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum
12
23
5.23
6.00
1.4
1.6
mg/l
0.6
1.1
—
7
12
(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum
12
23
5.23
6.00
1.4
1.6
mg/l
1.7
2.7
—
7
12
(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum
12
23
5.23
6.00
1.4
1.6
mg/l
1.0
0.4
—
5
12
(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum
12
23
5.23
6.00
1.4
1.6
mg/l
0.9
0.7
—
7
10
(3051651) Icteric interference index of Serum or Plasma
39
166
2.36
5.88
1.3
3.7
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
33
130
2.55
5.86
1.1
1.2
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
10
17
5.90
5.62
3.0
5.6
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
136
887
1.55
5.55
1.2
1.3
u/ml
3.7
7.4
0.99
16
136
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
183
2586
0.69
5.53
1.4
1.4
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
563
4638
1.25
5.45
3.0
3.2
ng/l
341.8
475.5
0.44
324
2990
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
103
635
1.64
5.32
2.3
2.9
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
424
3385
1.29
5.32
2.3
1.7
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
48
233
2.07
5.32
1.0
1.2
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
86
508
1.71
5.23
1.4
1.5
—
—
—
0
0
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
23
80
2.89
5.18
1.2
1.4
nmol/l
97.4
127.3
0.51
15
61
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
75
428
1.77
5.15
1.4
1.5
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
392
3112
1.29
5.14
4.7
5.8
mmol/l
1.0
1.0
2.09
358
2911
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
15
40
3.76
5.08
1.8
2.0
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
132
875
1.53
5.04
1.2
1.3
u/ml
2.0
6.9
—
8
92
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
29
116
2.51
5.03
1.3
1.8
u/l
9.8
13.2
2.71
29
111
(3035941) MCH [Entitic mass]
3525
34635
1.52
5.03
27.0
16.9
pg
30.2
30.1
2.92
3500
34279
(3023520) Reticulocytes [#/volume] in Blood
232
1712
1.38
5.03
2.5
2.7
e9/l
64.1
72.6
3.28
172
1273
(3007461) Platelets [#/volume] in Blood
3523
34613
1.51
5.01
27.2
17.0
e9/l
263.4
261.1
1.34
3482
33932
(3024731) MCV [Entitic volume]
3525
34637
1.52
5.00
27.1
17.0
fl
90.8
90.4
8.04
3500
34283
(3010813) Leukocytes [#/volume] in Blood
3526
34649
1.52
5.00
27.2
17.1
e9/l
6.5
6.7
3.41
3475
33903
(3019225) pH of Specimen
312
2412
1.32
4.98
3.9
3.7
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
14
36
3.90
4.98
1.0
1.0
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
426
3434
1.27
4.95
1.4
1.5
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
90
547
1.66
4.94
10.4
3.8
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
3525
34643
1.51
4.93
27.2
17.0
e12/l
4.5
4.5
1.30
3478
33909
(3012501) Base excess in Blood by calculation
87
526
1.67
4.88
3.4
3.6
mmol/l
2.3
2.4
0.16
63
332
(3000963) Hemoglobin [Mass/volume] in Blood
3525
34652
1.50
4.82
27.3
17.1
g/l
135.7
135.8
0.24
3501
34290
(3003338) MCHC [Mass/volume]
2637
27559
0.84
4.82
23.4
14.4
g/l
332.5
332.6
0.27
2620
27370
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
117
766
1.54
4.74
1.2
1.3
u/ml
53.0
36.8
0.42
12
74
(3004119) Hemoglobin [Mass/volume] in Venous blood
184
1321
1.41
4.70
4.7
3.0
g/l
133.1
130.6
0.92
179
1289
(4268621)
66
375
1.77
4.64
2.0
2.3
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
2584
24586
1.17
4.60
4.5
4.1
pmol/l
14.7
14.5
5.92
2376
22946
(3014051) Protein [Presence] in Urine by Test strip
100
642
1.57
4.44
2.1
2.0
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
89
556
1.62
4.43
1.2
1.3
u/ml
3.1
4.2
0.54
32
235
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
111
731
1.53
4.41
1.7
1.7
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
24
94
2.56
4.38
1.1
1.3
—
—
—
0
0
(3022313) Gas panel - Capillary blood
144
1005
1.45
4.32
4.3
3.2
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
56
311
1.81
4.27
1.3
1.5
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
208
2754
0.74
4.26
1.4
1.5
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
6
236
0.25
4.17
1.2
1.2
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
30
134
2.25
4.15
1.4
1.6
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
189
1397
1.37
4.11
4.1
3.2
kpa
5.2
5.1
0.26
178
1315
(3009343) pH of Capillary blood
187
1381
1.37
4.09
4.1
3.2
ph
7.4
7.4
0.92
23
174
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
29
129
2.26
4.05
1.1
1.1
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
452
3757
1.23
4.02
2.2
2.0
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
60
1002
0.59
4.02
1.3
1.5
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
74
1173
0.62
4.00
1.5
1.8
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
181
1336
1.37
3.98
4.1
3.2
mmol/l
2.0
1.6
1.08
154
997
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
129
897
1.45
3.97
4.9
6.1
%
1.9
1.7
0.89
120
835
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
118
807
1.48
3.96
1.9
2.1
ug/l
2.1
1.7
0.16
95
727
(3006462) Nitrate [Presence] in Urine
27
118
2.30
3.94
3.3
2.6
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
101
1490
0.67
3.91
1.6
1.7
mg/l
4.4
4.1
0.14
66
1039
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
794
6975
1.18
3.90
1.7
1.8
mg/l
0.8
1.0
1.02
578
5185
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
87
559
1.57
3.90
1.0
1.1
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
65
390
1.68
3.83
1.4
1.6
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
103
690
1.51
3.83
2.1
2.3
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
11
29
3.80
3.80
1.1
1.1
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
11
29
3.80
3.80
1.0
1.2
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
142
1015
1.42
3.79
3.3
3.2
mmol/l
25.9
25.3
1.27
134
981
(1616796) Gas panel - Central venous blood
79
500
1.59
3.78
2.9
3.1
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
82
525
1.57
3.74
2.4
3.2
umol/l
32.2
34.7
0.47
67
461
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
10
25
4.01
3.69
1.1
1.1
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
127
894
1.44
3.69
5.0
6.3
%
0.9
0.9
0.31
119
833
(3010421) pH of Blood
96
639
1.52
3.69
3.3
3.6
ph
7.4
7.4
0.71
85
519
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
61
365
1.68
3.65
1.3
1.4
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
64
388
1.66
3.64
1.3
1.3
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
25
110
2.28
3.61
1.3
1.3
—
—
—
0
0
(40768443) Skin Pathology biopsy report
159
1171
1.37
3.58
1.2
1.2
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
87
572
1.53
3.55
1.1
1.2
u/ml
2.0
3.7
1.32
25
189
(4024509)
43
234
1.85
3.55
1.7
1.4
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
295
2373
1.26
3.53
2.5
2.3
g/l
0.2
0.2
0.29
280
2236
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
88
582
1.52
3.50
3.3
5.8
iu/ml
324.4
418.6
—
5
70
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
101
688
1.48
3.50
1.2
1.3
u/ml
0.9
3.2
—
7
50
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
90
599
1.52
3.48
1.4
1.3
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
124
880
1.42
3.47
4.7
3.3
mmol/l
25.3
24.8
1.30
118
821
(3036481) Cortisol [Moles/volume] in Serum or Plasma
357
2945
1.24
3.43
2.0
2.1
nmol/l
353.6
372.3
1.14
325
2730
(3003694) ABO and Rh group [Type] in Blood
835
9333
0.86
3.41
1.6
1.6
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
132
951
1.40
3.40
1.5
1.9
g/l
1.4
1.5
0.70
113
827
(3021447) Carbon dioxide [Partial pressure] in Venous blood
254
2018
1.28
3.38
5.0
3.6
kpa
5.9
5.9
0.21
244
1955
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
25
114
2.20
3.34
1.3
1.3
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
252
2004
1.28
3.33
5.0
3.7
mmol/l
2.1
1.9
0.57
218
1621
(3020779) Urea [Moles/volume] in Serum or Plasma
244
1933
1.28
3.32
6.9
8.1
mmol/l
6.8
8.3
5.12
232
1857
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
330
2710
1.24
3.31
2.6
2.4
u/l
34.7
54.9
0.57
275
2345
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
38
204
1.87
3.29
1.1
1.2
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
36
191
1.89
3.24
1.2
1.6
u/l
5.3
5.8
0.43
29
160
(3022948) Iron [Moles/volume] in Serum or Plasma
481
4112
1.20
3.23
2.2
2.4
umol/l
13.7
14.1
0.45
440
3814
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
50
295
1.70
3.19
1.7
2.1
mg/l
20.8
22.1
0.08
16
81
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
11
33
3.34
3.19
1.0
1.1
ug/l
5.1
82.7
—
6
14
(3014271) Vancomycin [Susceptibility]
20
85
2.36
3.15
3.1
2.5
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
17
67
2.54
3.12
8.5
10.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
40
223
1.80
3.10
1.1
1.0
—
—
—
0
0
(3000492) Spirometry study
259
3191
0.80
3.10
1.3
1.4
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
12
39
3.08
3.09
1.0
1.1
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
53
321
1.66
3.08
1.4
1.5
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
640
5628
1.17
3.07
2.5
2.8
ng/l
738.9
919.2
1.11
537
4653
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
40
225
1.79
3.02
1.1
1.0
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
189
1471
1.30
2.98
1.6
1.5
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
763
6814
1.15
2.97
2.2
2.1
mg/l
2.9
2.8
0.25
658
5872
(3005082) Progesterone [Moles/volume] in Serum or Plasma
13
324
0.40
2.95
1.3
1.3
nmol/l
32.0
32.7
0.03
13
284
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
63
404
1.57
2.93
1.1
1.1
g/l
1.5
1.5
0.11
56
368
(3037121) Protein [Mass/volume] in Urine
118
858
1.39
2.93
3.1
3.2
g/l
0.3
0.3
0.05
51
352
(3028679) Herpes simplex virus Ab [Presence] in Serum
39
220
1.78
2.93
1.1
1.2
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
137
1809
0.75
2.84
1.4
1.4
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
48
291
1.66
2.81
1.4
1.6
—
—
—
0
0
(4211845)
27
137
1.98
2.79
3.3
2.6
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
692
7739
0.87
2.79
3.7
3.2
mmol/l
7.7
7.8
0.08
587
6662
(3004789) Transferrin [Mass/volume] in Serum or Plasma
435
3740
1.19
2.75
2.2
2.3
g/l
2.4
2.4
0.28
398
3470
(1002224) Polysomnography panel
117
1571
0.74
2.73
1.1
1.1
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
70
468
1.51
2.73
2.4
2.3
%
16.9
16.8
0.08
33
229
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
140
1060
1.33
2.71
1.3
1.4
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
2574
26615
0.89
2.68
4.6
4.7
mmol/mol
37.9
38.4
2.65
2384
25133
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
366
3106
1.20
2.68
3.8
3.8
%
31.2
31.8
0.53
273
2241
(3004716) Salmonella sp identified in Stool by Organism specific culture
154
1983
0.77
2.68
1.3
1.4
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
41
242
1.70
2.66
2.2
2.2
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
67
447
1.51
2.65
1.7
1.7
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
343
4037
0.83
2.63
1.8
1.9
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
302
2522
1.22
2.63
7.7
8.3
mmol/l
1.2
1.0
0.26
229
1961
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
355
3012
1.20
2.61
6.8
5.7
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
24
120
2.01
2.60
1.2
1.1
g/l
—
0.1
—
0
6
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
24
120
2.01
2.60
1.1
1.2
%
94.5
92.8
—
6
49
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
302
2525
1.21
2.60
7.7
8.2
kpa
5.0
5.1
0.42
286
2416
(3027801) Oxygen [Partial pressure] in Arterial blood
302
2525
1.21
2.60
7.7
8.2
kpa
12.6
12.9
0.38
287
2417
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
25
127
1.98
2.60
1.1
1.1
%
84.7
92.0
—
7
52
(3010726) Horse dander IgE Ab [Units/volume] in Serum
46
728
0.63
2.59
1.0
1.1
u/ml
0.4
1.6
—
10
178
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
124
932
1.34
2.54
2.1
2.5
%
158.8
176.2
1.61
117
883
(3047352) Trisomy 18 risk [Likelihood] in Fetus
88
1220
0.71
2.53
1.3
1.4
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
628
7024
0.87
2.52
4.5
4.0
mg/mmol
9.2
9.3
0.01
396
4488
(3005033) Fetal Nuchal fold Thickness US
88
1218
0.72
2.51
1.3
1.4
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
38
624
0.60
2.51
1.1
1.2
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
598
6706
0.87
2.49
3.8
3.3
mg/l
871.4
388.6
0.91
385
4204
(3003181) Sodium [Moles/volume] in Urine
53
341
1.56
2.48
1.5
1.4
mmol/l
57.6
66.3
0.94
39
281
(3024354) Oxygen [Partial pressure] in Venous blood
202
1628
1.25
2.46
5.0
3.0
kpa
5.0
4.7
0.92
191
1568
(3044009) aPTT.lupus sensitive (LA screen)
10
34
2.95
2.41
1.6
1.2
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
30
167
1.80
2.40
1.4
1.6
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
23
117
1.97
2.40
1.6
1.6
—
—
—
0
0
(3036489) Thrombin time
150
1170
1.29
2.39
1.8
2.1
s
20.7
21.0
0.53
133
992
(3014133) Dog dander IgE Ab [Units/volume] in Serum
40
640
0.62
2.38
1.1
1.1
u/ml
1.8
3.3
0.76
18
244
(3015235) Bicarbonate [Moles/volume] in Capillary blood
77
541
1.43
2.38
2.8
3.0
mmol/l
25.0
24.7
0.24
70
487
(3006922) Hepatitis E virus Ab [Presence] in Serum
40
243
1.65
2.37
1.1
1.1
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
33
190
1.74
2.37
3.2
1.8
u/field
2.3
1.7
0.30
16
98
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
847
7724
1.13
2.36
1.3
1.3
u/ml
1.0
1.5
1.04
204
2210
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
120
910
1.33
2.35
2.2
2.0
iu/l
7.1
4.2
1.35
47
360
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
790
7177
1.13
2.34
1.6
1.5
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
67
461
1.46
2.32
1.4
1.6
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
60
873
0.68
2.29
1.1
1.1
u/ml
1.1
1.3
0.09
19
345
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
19
92
2.07
2.27
1.3
1.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
19
92
2.07
2.27
1.3
1.3
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
34
201
1.70
2.24
1.5
1.1
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
94
1260
0.74
2.22
1.3
1.5
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
99
1314
0.75
2.20
1.4
1.5
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
240
2002
1.21
2.16
8.9
7.4
mmol/l
1.2
1.3
0.68
228
1925
(36660697) Celiac disease serology panel - Serum
319
2732
1.18
2.15
1.2
1.2
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
9
30
3.00
2.14
2.0
2.5
u/field
0.7
0.9
—
9
30
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
49
322
1.53
2.13
1.3
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
49
322
1.53
2.13
1.3
1.4
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
28
159
1.77
2.13
1.3
1.5
nmol/l
142.1
131.9
0.41
28
159
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
393
3428
1.16
2.12
2.3
2.4
%
23.0
23.8
0.49
327
2956
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
62
429
1.45
2.11
1.7
1.6
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
49
323
1.52
2.11
1.3
1.4
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
22
116
1.90
2.10
1.6
1.6
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
38
236
1.62
2.10
1.2
1.3
titre
242.9
221.2
—
7
51
(3005988) Vibrio sp identified in Specimen by Organism specific culture
49
324
1.52
2.08
1.3
1.4
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
39
245
1.60
2.06
1.3
1.5
umol/l
12.6
11.3
0.56
39
229
(3011325) HIV 1+2 Ab [Presence] in Serum
7
20
3.50
2.05
1.1
1.1
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
7
20
3.50
2.05
1.0
1.1
u/l
8.1
21.7
—
7
20
(3016502) Oxygen saturation in Arterial blood
264
2234
1.20
2.05
8.1
8.8
%
95.7
96.0
0.22
254
2156
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
6
15
4.00
2.04
1.0
1.0
—
—
—
0
0
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
6
15
4.00
2.04
1.2
1.1
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
49
326
1.51
2.03
1.3
1.4
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
30
177
1.70
2.02
1.3
1.1
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
5
144
0.35
2.01
3.0
3.0
mg/l
5.3
7.6
—
5
115
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
26
148
1.76
1.98
1.4
1.3
u/ml
15.8
20.1
—
8
28
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
42
272
1.55
1.97
1.3
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
42
272
1.55
1.97
1.3
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
42
272
1.55
1.97
1.3
1.1
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
49
329
1.50
1.96
1.3
1.4
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
53
362
1.47
1.95
1.4
1.6
mu/l
28.6
52.1
1.48
46
330
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
5
11
4.55
1.94
2.2
1.1
—
—
—
0
0
(4198724)
31
187
1.66
1.93
1.3
1.8
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
126
1587
0.79
1.92
1.4
1.5
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
77
565
1.37
1.92
3.5
3.4
mg/l
27.8
37.8
0.79
65
456
(3034860) Kappa light chains.free [Mass/volume] in Serum
77
565
1.37
1.92
3.5
3.4
mg/l
35.9
63.3
1.16
65
455
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
50
339
1.48
1.91
1.4
1.4
pmol/l
304.4
310.8
0.03
34
267
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
507
5643
0.88
1.89
1.2
1.3
u/ml
3.6
9.4
4.33
199
2398
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
35
543
0.64
1.89
1.5
1.4
mmol/l
5.9
7.1
2.80
23
395
(3008401) Mugwort IgE Ab [Units/volume] in Serum
53
756
0.70
1.88
1.0
1.1
u/ml
0.1
1.2
4.33
13
324
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
7
22
3.19
1.88
2.0
2.2
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
144
1157
1.25
1.87
10.4
10.5
mmol/l
24.6
24.3
0.63
139
1093
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
149
1202
1.25
1.87
9.9
11.5
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
108
1381
0.78
1.87
2.1
2.0
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
41
268
1.54
1.86
1.3
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
41
268
1.54
1.86
1.3
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
41
268
1.54
1.86
1.3
1.1
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
78
577
1.36
1.86
1.4
1.6
—
—
—
0
0
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
16
79
2.03
1.85
1.3
1.9
u/l
9.3
49.2
1.14
11
73
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
103
795
1.30
1.84
1.3
1.4
u/l
27.3
24.7
0.34
77
669
(3035880) pH of Pleural fluid
17
86
1.98
1.84
1.1
1.3
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
44
293
1.51
1.84
1.3
1.4
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
6
17
3.53
1.83
1.0
1.3
—
—
—
0
0
(3011648) Oxygen content in Venous blood
30
183
1.64
1.81
2.1
2.3
%
13.0
11.2
1.45
30
183
(3023430) Cat dander IgE Ab [Units/volume] in Serum
40
596
0.67
1.79
1.1
1.1
u/ml
2.5
3.3
0.22
13
240
(3002173) Hemoglobin [Mass/volume] in Arterial blood
247
2109
1.18
1.77
8.6
9.1
g/l
123.2
122.8
0.12
234
2032
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
5
136
0.37
1.75
3.0
2.4
—
107.1
—
0
20
(3019174) dRVVT (LA screen)
9
36
2.50
1.74
1.6
1.2
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
118
1475
0.79
1.72
1.3
1.4
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
192
2281
0.83
1.71
3.8
4.1
ug/l
5.1
39.3
1.44
148
1759
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
118
938
1.27
1.71
4.7
3.6
%
49.7
50.0
0.04
113
926
(3042631) Mycobacterium sp identified in Specimen
39
258
1.52
1.70
1.9
2.7
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
118
1470
0.80
1.67
1.3
1.4
—
—
—
0
0
(3044889) 12 lead EKG panel
2040
19668
1.08
1.67
3.2
3.1
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
493
4449
1.12
1.65
2.5
2.7
mmol/l
2.4
2.4
0.61
416
3907
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
119
1476
0.80
1.63
1.3
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
119
1475
0.80
1.62
1.3
1.4
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
58
790
0.73
1.61
1.0
1.1
u/ml
4.7
5.5
0.15
28
419
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
2823
28814
0.91
1.59
3.8
3.8
mmol/l
5.7
5.8
2.31
2591
26888
(1617658) Protocol used for examination of sentinel lymph nodes
14
262
0.53
1.58
1.0
1.1
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
21
121
1.74
1.58
1.0
1.2
—
3.8
—
0
10
(3019060) Gas panel - Arterial blood
167
1393
1.21
1.58
4.4
5.7
—
—
—
0
0
(3008898) HLA-B27 [Presence]
125
1533
0.81
1.56
1.1
1.1
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
52
372
1.40
1.56
2.7
2.6
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
23
137
1.68
1.55
1.8
1.7
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
7
158
0.44
1.54
1.0
1.1
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
58
783
0.74
1.53
1.4
1.4
nmol/l
0.4
0.4
0.01
43
634
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
73
554
1.32
1.52
3.5
3.4
ratio
1.2
1.6
—
6
53
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
14
258
0.54
1.52
1.1
1.2
u/ml
0.0
0.5
—
6
91
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
23
138
1.67
1.51
2.8
2.4
umol/l
60.5
50.5
0.96
23
117
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
17
93
1.83
1.51
2.8
2.9
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
76
584
1.31
1.46
1.4
1.6
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
7
28
2.50
1.45
2.0
2.0
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
14
73
1.92
1.43
1.1
1.1
—
—
—
0
0
(3023383) Lactate [Moles/volume] in Pleural fluid
9
39
2.31
1.43
1.2
1.1
mmol/l
4.1
3.3
—
9
34
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
39
553
0.70
1.41
2.1
2.6
ug/min
71.4
104.9
0.34
25
342
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
76
588
1.30
1.40
1.6
1.6
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
2346
24082
0.93
1.40
3.4
3.5
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
10
46
2.18
1.39
2.1
2.0
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
6
139
0.43
1.39
1.2
1.0
—
—
—
0
0
(3004451) EKG impression Narrative
17
96
1.77
1.38
1.1
1.2
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
38
263
1.45
1.38
1.2
1.7
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
5
17
2.94
1.36
1.0
1.1
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
660
7104
0.91
1.33
2.2
2.3
umol/l
2362.0
3539.0
0.58
576
6331
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
40
283
1.42
1.31
1.1
1.1
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
15
83
1.81
1.31
3.1
2.1
umol/l
11.7
16.2
1.06
15
83
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
24
2.50
1.30
1.0
1.0
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
109
891
1.23
1.30
1.2
1.1
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
9
43
2.10
1.30
1.2
2.2
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
37
259
1.43
1.29
1.4
1.5
mosm/kgh2o
277.4
281.3
0.25
27
208
(3017509) Phencyclidine [Presence] in Urine
10
48
2.09
1.27
1.2
1.2
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
17
99
1.72
1.27
1.2
1.2
u/l
35.5
10.8
0.52
17
90
(40760888) Immunoglobulin light chains.free panel - Serum
56
423
1.33
1.25
3.8
3.6
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
62
476
1.31
1.24
6.7
2.9
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
17
100
1.70
1.23
2.9
2.4
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
122
1016
1.21
1.23
2.0
2.3
%
98.7
94.3
1.56
115
938
(3009466) Valproate [Moles/volume] in Serum or Plasma
58
442
1.32
1.23
4.2
5.8
umol/l
384.8
369.9
0.29
47
386
(3012441) Differential panel - Pleural fluid
24
155
1.55
1.22
1.2
1.5
—
—
—
0
0
(3001893) Eosinophils/100 leukocytes in Pleural fluid
10
49
2.04
1.22
1.0
1.5
%
1.5
3.7
—
10
42
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
5
19
2.63
1.21
1.0
1.2
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
205
1788
1.16
1.21
3.4
3.7
ng/l
73.2
79.3
0.51
177
1599
(3028308) Erythrocytes [#/volume] in Pleural fluid
25
164
1.53
1.20
1.3
1.4
e6/l
29815.9
65455.7
0.40
12
92
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
40
289
1.39
1.19
1.1
1.1
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
35
247
1.42
1.18
1.6
1.8
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
43
315
1.37
1.18
1.5
1.6
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
10
50
2.00
1.16
2.0
2.5
—
—
—
0
0
(4015189)
10
50
2.00
1.16
1.1
3.1
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
34
0.00
1.16
0.0
2.0
—
62.9
—
0
29
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
74
589
1.26
1.15
1.2
1.3
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
31
216
1.44
1.13
2.7
2.0
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
13
73
1.78
1.10
2.7
4.7
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
17
104
1.64
1.09
1.2
1.3
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
32
227
1.41
1.07
1.3
1.5
mmol/l
6.4
6.3
0.11
27
163
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
25
169
1.48
1.07
1.6
1.6
u/l
3.0
6.0
0.68
11
92
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
17
105
1.62
1.06
3.6
3.2
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
232
2601
0.88
1.05
1.3
1.3
iu/l
28.7
26.9
0.34
212
2255
(4094501)
56
712
0.78
1.04
1.1
1.1
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
13
75
1.74
1.02
1.3
1.1
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
468
4332
1.09
1.02
2.1
2.4
ug/g
124.1
107.5
0.35
342
3468
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
704
7469
0.93
1.01
1.5
1.6
mmol/l
1.4
1.4
0.01
582
6458
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
10
53
1.89
1.01
1.1
1.2
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
27
188
1.44
1.01
1.3
1.4
e6/l
38741.4
3035.0
0.45
18
128
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
37
273
1.36
1.00
1.2
1.2
u/l
42.6
58.7
1.37
24
184
(3000919) Neutrophils/100 leukocytes in Pleural fluid
9
49
1.84
0.98
1.0
1.4
%
28.1
27.4
—
9
44
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
14
84
1.67
0.97
1.1
1.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
30
412
0.73
0.97
1.3
1.5
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
92
769
1.20
0.95
3.1
2.8
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
25
174
1.44
0.95
1.1
1.3
mmol/l
5.4
6.3
0.93
25
159
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
33
242
1.37
0.94
1.2
1.1
ratio
1.1
1.0
0.72
11
88
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
256
2311
1.12
0.93
3.3
3.4
pmol/l
4.4
4.5
0.84
224
2069
(4281824)
23
328
0.70
0.93
1.0
1.2
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
52
410
1.27
0.91
1.5
1.7
—
—
—
0
0
(3036603) Volume of Urine
26
184
1.42
0.91
2.3
1.4
ml
2054.4
2181.7
—
7
31
(3032773) Endomysium IgG Ab [Titer] in Serum
38
287
1.33
0.91
1.1
1.1
—
—
—
0
0
(3000991) Gas panel - Venous blood
210
1879
1.12
0.90
11.3
9.0
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
22
151
1.46
0.90
1.3
1.5
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
24
168
1.43
0.89
1.3
1.6
—
—
—
0
0
(3003721) Smooth muscle Ab [Units/volume] in Serum
6
29
2.07
0.89
1.2
1.2
—
2.7
—
0
5
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
262
2884
0.90
0.89
2.6
2.7
ug/l
0.6
0.7
1.85
173
1698
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
34
254
1.34
0.88
1.3
1.1
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
40
307
1.31
0.87
8.5
6.7
mg/l
10.8
11.1
0.17
34
281
(3042111) Morphology [Interpretation] in Bone marrow Narrative
45
352
1.28
0.85
1.3
1.7
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
52
415
1.26
0.84
1.3
1.2
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
156
1377
1.14
0.84
6.7
7.9
mmol/l
24.3
24.4
0.05
142
1280
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
6
31
1.94
0.84
1.2
1.1
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
118
1022
1.16
0.83
1.1
1.1
u/ml
1.1
4.3
2.57
12
153
(3041806) Other cells [#/volume] in Blood by Manual count
10
166
0.60
0.83
1.5
1.6
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
70
580
1.21
0.82
1.0
1.1
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
1534
14895
1.05
0.80
2.9
2.9
ug/l
104.9
92.3
1.24
1446
14066
(3047181) Lactate [Moles/volume] in Blood
86
730
1.18
0.79
5.4
7.3
mmol/l
1.1
1.2
0.86
74
638
(40768795) Lymph node Pathology biopsy report
19
270
0.70
0.78
1.0
1.2
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
31
234
1.33
0.77
3.6
2.3
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
18
123
1.47
0.77
1.3
1.2
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
67
802
0.83
0.77
3.1
3.6
u/ml
523.5
1700.3
0.42
57
684
(3035509) Tobramycin [Mass/volume] in Serum or Plasma
0
28
0.00
0.76
0.0
2.6
—
1.5
—
0
20
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
12
185
0.65
0.75
1.1
1.4
pmol/l
97.2
226.5
—
6
59
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
13
196
0.66
0.73
1.5
1.2
—
—
—
0
0
(3026250) Tacrolimus [Mass/volume] in Blood
8
133
0.60
0.73
61.1
36.1
ug/l
8.7
7.4
—
8
122
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
44
352
1.25
0.73
1.1
1.2
—
—
—
0
0
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
5
25
2.00
0.72
1.4
1.2
—
9.6
—
0
8
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
31
400
0.77
0.71
1.5
1.6
mmol/l
7.5
7.6
0.10
19
250
(3026389) Candida sp identified in Specimen by Organism specific culture
55
453
1.22
0.71
1.5
1.2
—
—
—
0
0
(3017704) Immunofixation for Urine
16
109
1.47
0.70
2.4
1.6
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
29
221
1.31
0.69
1.2
2.0
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
22
297
0.74
0.69
1.5
1.5
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
11
169
0.65
0.69
1.5
1.2
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
121
1069
1.14
0.68
6.6
3.9
mmol/l
24.5
24.2
0.69
111
969
(3045683) HLA typing for celiac disease panel - Blood or Tissue
18
250
0.72
0.68
1.0
1.0
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
32
407
0.78
0.67
1.7
1.6
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
38
473
0.80
0.66
2.6
2.5
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
1357
13948
0.96
0.65
4.0
3.8
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
162
1790
0.90
0.64
2.8
2.0
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
35
438
0.80
0.64
1.2
1.2
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
54
452
1.20
0.61
1.3
1.1
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
255
2363
1.09
0.61
1.2
1.3
u/ml
128.5
185.6
1.01
234
2196
(3027008) Opiates [Presence] in Urine
164
1802
0.91
0.60
2.8
2.0
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
21
0.00
0.60
0.0
1.9
—
47.4
—
0
21
(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
63
735
0.85
0.58
1.2
1.3
ug/l
2.5
3.7
1.61
57
675
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
23
0.00
0.58
0.0
1.0
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
48
573
0.84
0.58
2.6
2.4
nmol/l
0.9
0.8
0.07
36
494
(3028300) Cannabinoids [Presence] in Urine
165
1807
0.91
0.57
2.8
2.0
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
8
54
1.48
0.57
1.3
1.3
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
6
36
1.67
0.56
1.0
1.0
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
1287
12535
1.04
0.56
2.0
2.0
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
5
88
0.57
0.56
1.4
3.0
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
5
88
0.57
0.56
2.8
6.0
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
6
37
1.62
0.55
1.0
1.0
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
76
663
1.15
0.55
1.9
1.8
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
515
4912
1.06
0.55
3.7
4.1
ug/l
1.6
2.0
2.45
459
4455
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
43
357
1.21
0.55
1.3
1.3
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
10
148
0.67
0.55
1.6
2.3
ug/l
28.1
361.2
—
10
135
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
62
719
0.86
0.54
1.1
1.2
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
8
122
0.66
0.54
1.1
1.0
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
155
1697
0.91
0.54
1.7
1.6
mu/l
327.6
294.9
0.48
139
1514
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
63
729
0.86
0.54
1.9
3.3
mg/l
1.3
1.4
0.29
55
687
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
15
205
0.73
0.54
1.6
1.9
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
59
506
1.17
0.53
6.7
8.9
mmol/l
105.3
105.5
0.09
54
451
(3045142) Bone marrow Pathology biopsy report
20
261
0.76
0.53
1.2
1.4
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
9
62
1.45
0.53
1.0
1.2
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
9
62
1.45
0.53
1.0
1.2
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
9
62
1.45
0.53
1.0
1.2
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
9
62
1.45
0.53
1.0
1.2
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
54
630
0.85
0.52
1.9
2.1
umol/l
4.5
4.9
0.25
41
452
(3028717) Thiamine [Mass/volume] in Blood
6
40
1.50
0.51
1.3
1.2
—
—
—
0
0
(4146454)
17
225
0.75
0.50
2.1
2.7
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
19
247
0.77
0.50
1.3
1.3
—
1.6
—
0
13
(3006270) Folate [Moles/volume] in Blood
30
243
1.24
0.49
1.0
1.1
nmol/l
393.7
396.9
0.03
24
229
(40768446) Kidney Pathology biopsy report
7
109
0.64
0.48
1.6
1.6
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
25
199
1.26
0.47
2.8
2.1
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
22
278
0.79
0.47
1.4
1.4
g/l
0.8
1.0
0.80
22
278
(3042517) Benzodiazepines panel - Urine
7
47
1.49
0.47
1.6
2.4
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
42
355
1.19
0.47
1.3
1.3
—
31.6
—
0
7
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
293
2766
1.06
0.46
1.3
1.2
iu/ml
165.5
163.2
0.03
124
1067
(3027944) Amphetamines [Presence] in Urine
164
1772
0.92
0.45
2.6
2.0
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
35
292
1.20
0.45
2.8
2.6
—
—
—
0
0
(3039000) Anion gap in Blood
58
506
1.15
0.45
6.8
8.9
mmol/l
10.9
11.4
0.68
53
451
(3001964) Herpes simplex virus Ag [Presence] in Specimen
12
86
1.40
0.44
2.1
1.5
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
27
220
1.23
0.43
1.2
1.3
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
64
564
1.14
0.43
5.5
3.3
mg/l
24.4
22.5
0.12
35
350
(3043409) Potassium [Moles/volume] in Arterial blood
75
668
1.13
0.43
3.7
4.3
mmol/l
3.8
3.8
0.02
66
627
(3044927) Protein electrophoresis panel - Urine
24
193
1.25
0.43
1.5
1.2
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
15
196
0.76
0.42
1.3
1.3
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
174
1619
1.08
0.42
2.3
2.9
ng/l
99.1
149.2
2.64
148
1442
(4035726)
215
2290
0.94
0.42
1.4
1.4
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
21
262
0.80
0.42
1.2
1.2
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
40
467
0.85
0.41
1.5
1.6
—
—
—
0
0
(3035611) Eosinophils/100 leukocytes in Synovial fluid
0
15
0.00
0.41
0.0
1.7
—
0.1
—
0
9
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
0
15
0.00
0.41
0.0
1.6
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
21
261
0.80
0.41
13.2
18.9
nmol/l
890.6
5185.0
0.62
16
252
(40758358) Immune stain study
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
0
17
0.00
0.40
0.0
1.1
—
8.1
—
0
17
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
31
369
0.84
0.40
1.4
1.5
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
287
2723
1.06
0.40
15.3
17.9
inr
1.1
1.2
0.84
59
413
(3000285) Sodium [Moles/volume] in Blood
5
34
1.47
0.40
1.2
1.0
—
—
—
0
0
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
17
132
1.29
0.40
1.2
1.0
ng/l
771.4
744.2
0.08
11
85
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
17
132
1.29
0.40
1.2
1.0
ng/l
204.7
289.9
1.67
11
88
(44813793)
21
260
0.81
0.40
1.1
1.1
—
—
—
0
0
(3001729) Color of Synovial fluid
0
18
0.00
0.40
0.0
1.7
—
—
—
0
0
(3013945) Hepatitis B virus e Ab [Presence] in Serum
0
18
0.00
0.40
0.0
1.6
—
—
—
0
0
(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid
0
18
0.00
0.40
0.0
1.4
—
5203.0
—
0
13
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
5
35
1.43
0.39
1.0
1.9
—
—
—
0
0
(4034850)
87
959
0.90
0.39
8.3
8.2
—
—
—
0
0
(3027974) Hepatitis B virus e Ag [Presence] in Serum
0
19
0.00
0.39
0.0
1.6
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
186
1747
1.07
0.37
1.9
2.2
nmol/l
12.4
12.1
0.19
167
1563
(3020874) Milk IgE Ab [Units/volume] in Serum
22
268
0.82
0.37
1.1
1.0
u/ml
0.3
2.6
—
6
82
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
5
37
1.35
0.37
1.0
1.1
umol/24h
1.3
1.7
—
5
37
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
17
134
1.27
0.36
1.2
1.0
ng/l
26.3
42.1
2.35
11
86
(40768793) Breast Pathology biopsy report
70
774
0.90
0.35
1.3
1.3
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
204
1928
1.06
0.34
1.1
1.1
—
—
—
0
0
(3019977) pH of Arterial blood
15
118
1.27
0.33
1.9
3.7
ph
7.4
7.4
—
6
32
(3043410) Blood group antigens tested for on Red Blood Cells
6
88
0.68
0.33
2.0
1.3
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
30
258
1.16
0.31
3.1
2.2
pg
32.6
32.0
0.50
30
258
(44806071)
7
54
1.30
0.30
1.1
1.1
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
57
514
1.11
0.30
2.5
2.1
g/l
130.0
131.6
0.21
48
377
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
10
130
0.77
0.29
1.2
1.1
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
7
57
1.23
0.29
1.0
1.1
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
14
112
1.25
0.28
1.1
1.6
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
14
112
1.25
0.28
1.1
1.6
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
16
131
1.22
0.27
2.8
3.1
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
46
511
0.90
0.27
1.1
1.1
iu/ml
4.4
16987.0
0.54
12
138
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
61
557
1.10
0.27
1.1
1.1
—
—
—
0
0
(44806118)
33
291
1.14
0.26
1.4
1.6
—
—
—
0
0
(44790048)
33
291
1.14
0.26
1.4
1.6
—
—
—
0
0
(44790047)
33
291
1.14
0.26
1.4
1.6
—
—
—
0
0
(44790049)
33
291
1.14
0.26
1.4
1.6
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
203
1942
1.05
0.25
1.3
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
87
933
0.93
0.25
1.2
1.1
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
13
105
1.24
0.24
1.4
1.2
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
69
746
0.92
0.24
1.8
1.6
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
11
137
0.80
0.24
1.2
1.1
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
9
77
1.17
0.24
1.8
3.4
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
9
77
1.17
0.24
1.8
3.4
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
16
133
1.20
0.24
1.4
1.7
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
16
133
1.20
0.24
1.4
1.7
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
16
133
1.20
0.24
1.4
1.7
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
16
133
1.20
0.24
1.4
1.7
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
10
126
0.79
0.24
1.0
1.0
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
158
1658
0.95
0.24
2.8
2.1
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
40
360
1.11
0.23
1.5
1.5
—
—
—
0
0
(4306422)
63
582
1.08
0.23
1.1
1.2
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
202
2104
0.96
0.23
1.2
1.2
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
75
699
1.07
0.22
1.2
1.4
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
79
738
1.07
0.22
1.2
1.2
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
5
41
1.22
0.22
1.0
1.0
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
70
652
1.08
0.21
1.2
1.4
u/ml
165.4
109.9
0.44
14
144
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
5
42
1.19
0.21
1.2
1.5
—
—
—
0
0
(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
0
11
0.00
0.21
0.0
2.7
—
—
—
0
0
(3034614) HLA Ag [Interpretation]
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method
0
10
0.00
0.21
0.0
12.7
—
—
—
0
0
(3049242) von Willebrand panel - Platelet poor plasma
0
10
0.00
0.21
0.0
1.8
—
—
—
0
0
(3004347) Hepatitis D virus Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3013862) HLA-DP [Type]
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3012989) Citrate [Moles/time] in 24 hour Urine
0
10
0.00
0.21
0.0
1.6
—
2.7
—
0
10
(40760410) HLA-B [Type] by High resolution
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
89
946
0.94
0.21
1.2
1.2
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
19
220
0.86
0.21
3.4
2.7
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
19
220
0.86
0.21
1.6
1.5
%
29.7
34.2
0.26
12
132
(44816559) Phosphatidylethanol [Mass/volume] in Blood
65
699
0.93
0.21
1.2
1.3
—
—
—
0
0
(3014591) Smooth Alder IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
75
701
1.07
0.21
1.2
1.2
u/ml
303.7
265.1
0.36
44
462
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
670
6826
0.98
0.20
2.2
2.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
526
5147
1.03
0.20
1.9
2.0
—
—
—
0
0
(40768441) Liver Pathology biopsy report
26
230
1.13
0.20
1.3
1.4
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
14
117
1.20
0.20
1.0
1.1
u/ml
0.0
3.9
—
8
60
(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid
0
14
0.00
0.20
0.0
10.3
—
114.2
—
0
9
(3013762) Body weight Measured
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
6
48
1.25
0.20
1.0
1.3
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
31
278
1.12
0.20
1.1
1.1
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
6
49
1.22
0.20
1.3
1.3
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
9
115
0.78
0.20
1.7
1.5
—
—
—
0
0
(3034426) Prothrombin time (PT)
15
127
1.18
0.19
1.3
1.3
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
135
1290
1.05
0.19
2.5
2.3
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
24
212
1.13
0.19
6.0
6.9
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
169
1624
1.04
0.19
1.5
1.5
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
123
1289
0.95
0.19
1.7
1.7
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
63
588
1.07
0.19
1.1
1.0
u/ml
1.3
3.4
2.60
24
305
(3048879) Bone marrow aspiration report
6
52
1.15
0.19
1.7
2.3
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
47
509
0.92
0.19
1.1
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
89
940
0.95
0.18
1.2
1.1
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
7
59
1.19
0.18
1.0
1.1
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
428
4372
0.98
0.17
1.8
1.8
%
1.5
1.4
1.96
390
3923
(3000570) Elastase.pancreatic [Mass/mass] in Stool
79
747
1.06
0.17
1.5
1.4
ug/g
290.2
300.3
0.14
39
390
(3002256) Pathology report gross observation
371
3793
0.98
0.16
1.3
1.2
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
8
72
1.11
0.16
1.0
1.0
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
163
1576
1.04
0.15
1.4
1.5
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
62
657
0.94
0.15
1.8
1.8
—
—
—
0
0
(3012565) Volume of 24 hour Urine
12
140
0.86
0.15
1.6
2.5
ml
1886.7
1986.8
0.18
12
129
(4010399)
197
1914
1.03
0.14
1.5
1.4
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
56
594
0.94
0.14
1.4
1.7
e6/l
8796.3
9889.6
0.12
39
429
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
47
501
0.94
0.14
2.8
2.7
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
382
3893
0.98
0.14
3.3
3.6
%
21.1
21.2
0.05
153
1587
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
39
363
1.08
0.13
1.1
1.2
u/l
14.7
36.0
1.80
34
315
(3047189) Immunofixation for 24 hour Urine
8
96
0.83
0.13
2.5
1.6
—
—
—
0
0
(3024932) HLA-DR beta [Type]
8
98
0.82
0.13
1.0
1.1
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
8
98
0.82
0.13
1.0
1.2
—
—
—
0
0
(3024471) HLA-A [Type]
8
98
0.82
0.13
1.0
1.0
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
27
247
1.09
0.13
1.3
1.1
—
—
—
0
0
(3020891) Body temperature
90
863
1.04
0.13
5.3
4.8
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
24
219
1.10
0.12
1.3
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
24
219
1.10
0.12
1.3
1.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
24
219
1.10
0.12
1.3
1.6
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
187
1920
0.97
0.12
1.9
2.8
u/ml
25.3
42.9
2.41
181
1862
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
756
7644
0.99
0.12
1.6
1.6
—
—
—
0
0
(3022145) Colonoscopy Study observation
330
3241
1.02
0.12
1.4
1.3
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
346
3517
0.98
0.11
1.9
1.9
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
113
1166
0.97
0.11
1.2
1.3
u/l
11.9
10.7
0.39
92
981
(3048929) Epstein Barr virus Ab [Presence] in Serum
124
1204
1.03
0.10
1.2
1.2
—
—
—
0
0
(3000012) Reticulocyte production index
13
115
1.13
0.10
1.4
1.6
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
586
5793
1.01
0.10
2.1
2.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
2943
29500
0.99
0.10
19.1
12.2
%
39.9
40.2
1.08
2171
23591
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
63
657
0.96
0.10
7.1
3.7
u/ml
0.4
0.3
0.43
35
368
(1001926) Buprenorphine [Presence] in Urine by Screen method
136
1396
0.97
0.10
3.0
2.1
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
5
45
1.11
0.09
1.0
1.3
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
12
135
0.89
0.09
1.2
1.1
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
587
5930
0.99
0.09
1.3
1.3
iu/ml
16.7
27.3
2.42
136
1877
(3005011) Chlamydia sp Ab [Titer] in Serum
6
55
1.09
0.08
1.5
1.5
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
32
302
1.06
0.08
1.2
1.4
mmol/l
9.5
12.9
1.97
11
59
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
6
58
1.03
0.08
1.7
1.6
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
5
61
0.82
0.08
1.0
1.2
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
5
61
0.82
0.08
1.0
1.2
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
5
63
0.79
0.08
1.0
1.2
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
5
63
0.79
0.08
1.0
1.2
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
5
63
0.79
0.08
1.0
1.2
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
5
63
0.79
0.08
1.0
1.2
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
17
185
0.92
0.08
2.3
1.3
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
403
3986
1.01
0.07
1.2
1.2
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
17
184
0.92
0.07
1.5
1.6
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
9
85
1.06
0.07
1.1
1.2
—
—
—
0
0
(4133840)
8
92
0.87
0.06
1.1
1.2
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
58
561
1.03
0.06
1.6
1.8
pmol/l
227.6
197.9
0.99
53
525
(3042733) HLA Ab [Presence] in Serum
9
101
0.89
0.06
5.0
4.8
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
9
100
0.90
0.06
1.1
1.1
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
9
102
0.88
0.06
3.4
2.4
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
9
103
0.87
0.06
1.7
2.7
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
488
4840
1.01
0.06
1.5
1.7
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
67
688
0.97
0.05
1.0
1.1
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
10
90
1.11
0.05
2.8
1.4
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
21
198
1.06
0.05
3.3
3.7
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
67
687
0.97
0.05
1.0
1.1
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
12
110
1.09
0.05
1.5
1.8
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
12
110
1.09
0.05
1.5
1.8
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
124
1220
1.02
0.05
3.9
2.8
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
61
625
0.98
0.04
1.1
1.2
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
13
121
1.07
0.03
1.6
2.5
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
23
240
0.96
0.03
2.0
1.7
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
914
9114
1.00
0.03
2.3
2.1
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
272
2706
1.01
0.02
1.8
1.8
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
16
153
1.05
0.01
1.5
2.8
umol/l
276.7
183.3
—
7
83
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
23
223
1.03
0.01
1.2
1.2
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
36
367
0.98
0.01
3.9
4.5
u/ml
19.4
74.2
—
8
104
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
176
1752
1.00
0.01
2.0
2.2
ug/l
6.0
6.9
0.42
150
1559
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
17
176
0.97
0.00
1.8
1.9
—
—
—
0
0
(21494434) Karyotype in Bone marrow
19
184
1.03
0.00
1.1
1.3
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
23
224
1.03
0.00
1.2
1.4
e6/l
20330.3
62815.2
0.71
17
153
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
29
296
0.98
0.00
1.7
1.6
%
46.6
58.1
0.78
21
181
(3003327) Ova and parasites identified in Stool by Light microscopy
117
1176
0.99
0.00
1.8
1.8
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
10
102
0.98
0.00
1.9
1.5
ug/l
9.1
8.1
—
10
102
(3035933) Granulocytes/100 leukocytes in Blood
12
118
1.02
0.00
1.3
1.6
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
12
118
1.02
0.00
1.0
1.2
—
—
—
0
0
(3024263) Appearance of Synovial fluid
12
122
0.98
0.00
1.3
2.1
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
13
132
0.98
0.00
1.1
1.2
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
219
2192
1.00
0.00
1.9
2.4
ml/min/173m2
79.0
73.2
1.61
90
818
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
11
111
0.99
0.00
1.5
1.8
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
18
179
1.01
0.00
1.9
1.8
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
25
251
1.00
0.00
2.4
1.6
promille
1.2
1.3
0.11
20
201
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
65
649
1.00
0.00
1.3
1.4
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
31
314
0.99
0.00
1.1
1.1
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
24
244
0.98
0.00
1.3
1.5
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
20
204
0.98
0.00
1.3
1.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
23
233
0.99
0.00
1.2
1.2
—
—
—
0
0
(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine
0
9
0.00
0.00
0.0
1.0
—
1033.4
—
0
9
(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
55
550
1.00
0.00
1.1
1.2
—
—
—
0
0
(3001218) Citrate [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3042934) Triiodothyronine (T3) Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
5
53
0.94
0.00
1.8
1.7
—
—
—
0
0
(3008860) Bordetella pertussis IgM Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
9
0.00
0.00
0.0
2.0
—
—
—
0
0
(3022670) pH of Venous cord blood
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
23
230
1.00
0.00
1.2
1.2
—
—
—
0
0
(3027305) Fractional oxyhemoglobin in Arterial cord blood
0
6
0.00
0.00
0.0
1.3
—
35.8
—
0
6
(3027859) Formaldehyde IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(36303722) Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
29.5
—
0
8
(40763641) Cell count and Differential panel - Peritoneal dialysis fluid
0
6
0.00
0.00
0.0
5.0
—
—
—
0
0
(3028714) Urate [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003157) Bacteria [#/volume] in Mother's milk
0
6
0.00
0.00
0.0
8.0
—
—
—
0
0
(44806420)
5
49
1.02
0.00
2.6
2.4
—
—
—
0
0
(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003593) Leptospira sp IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3020911) Cortisol [Moles/time] in 24 hour Urine
0
9
0.00
0.00
0.0
1.1
—
123.5
—
0
9
(3027696) Helicobacter pylori Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.2
—
832.0
—
0
5
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
9
0.00
0.00
0.0
2.0
—
—
—
0
0
(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002079) Sodium [Moles/time] in 24 hour Urine
0
9
0.00
0.00
0.0
1.1
—
129.3
—
0
9
(3008640) Bordetella pertussis IgG Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002719) Hemoglobin [Mass/volume] in Urine
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3020093) Fractional oxyhemoglobin in Venous cord blood
0
7
0.00
0.00
0.0
1.3
—
68.5
—
0
7
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001409) Leptospira sp IgM Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
9
0.00
0.00
0.0
2.0
—
—
—
0
0
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(36304315) Certolizumab Ab [Units/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3038385) Creatinine [Moles/volume] in Peritoneal fluid
0
7
0.00
0.00
0.0
1.1
—
167.6
—
0
7
(3003531) Amoxicillin IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007919) Fasciola sp Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012932) Hazelnut IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
7.7
—
0
5
(3037692) Legionella sp identified in Specimen by Organism specific culture
8
84
0.95
0.00
2.1
1.6
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: G6_DEMYEL – Demyelinating diseases of the central nervous system
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).